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Dear Dr. Fredrickson:

I write in behalf of the membership

.,• •,.

American

A.Hocht:io11 of cancer Institutes to indicate their overvhel.Jling

sentiment against conducting a clinical trial of Laetrile
because there is no apparent sound scientific basis for such
an undertaking.
After considering the matter in some detail, the Clinical
Research Committee of our organization adopted a resolution
which was later approved by the Board of Directors and submitted
t o ~he membership. Of the 37 institutions answering the poll,
_!!.!,!..J>ut I. ~pressPd their l!_~~ivoc~1i~}?Pt>Sit!on to a trial.
Those who would "go a!or.g vi th a tria
indicated that they were
yielding to the current public clamor and not responding to the
same sort of objective evidence that would be required of all
other potential anticancer co:::ipounds.
We sumit this expression of op inion to you, hoping that
it may serve a construc tive purpose. In the course of discharging
your r esp1>nsibilities, doubtless you receive many expressions of
opinion. In this ca se , the A~sociation thought you might like
to know the thoughts q[__sever ~ i v iduals who play important
roles io our national cancer effort.~
tt,a.

'1

Sinc erely.
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I write in behalf of the membership of
Cancer ln!ltitutes to indicate thei r ove.rwhelming
sentiment against conducting a clinical t r ial of Laetrile
becau!le there is no apparent s ound scientific basis for such
ao Jnder t ak.i ng .
~nc ia.t ~

Af t er consideri ng the matter in sonie deta il , t he Clinical
Research Committee of our orga nizati on adopted a resolution
which was later approved by the Boar d of Directors and s ubmitted
~o the membership . Of the 37 insti tuti ons answering the pol l,
all but 6 e.xpre!lsed their unequivocal opposition t o a trial .
Those v bo would " go along with a trial" indi ca ted that t l:ey were
yielding t o t be cur rent public cl amor and not responding to the
same s ort of obj ective evidence t hat would be r equired of all
otr.er potential anti cancer compounds .
We submit t his expr ession of op i nion t o you, hoping that
it may ser v e a construc t ive purpose. In the course of discharging
your res ponsibilities, doubtless you r eceive many expressions of
opinion. In this case , the Association thought you might like
t o know the thoughts of s everal individuals who play important
r o les in our national canc er effort.

G. ~ nman H.a ro,rnond, \I D
Lo• -I "!Nit• CJ, • ,,,,.,

Sincer ely.
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Albert R. Owens , Jr.• , M.D.
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October 18, 1977

Dr. William W. Slwlgi.ton
P,..ldecat, Aaaoc•uoa of AWlc:an
C.acer IMtlba.tea
DukeCQ •nthee•nieCancerCuts
Dab Valftratty M..Uoal C....._
D•bul, North Cuol1aa 271!0
D• r 1111:
l WOllld like to nt00. . .Dd Dr. C. 8. Jackaon, Olnctar of txtra■ural
,..,.... , at our lUUtutlon u the AACJ llaiaon NPN■entlU.. to tbe
Aaert•n alood Collualaaioe. Doc:tm Jaokson, wbo la a beao-onoologtat,
baa waned ...... ■!W9ly bl tbe blood PIV1'NID w:llb tbe lutJtute of Bemothenpy
ill BouallOD aDd baa lktmed 8Jld
me 1D ma111 ana• of the blood
PI0918• for Ille Awloan Cancer Society.

••&J.•ted

S lncerely your1 ,

R. Lee Clark, M. D.
Pruldeat
RLC:Jh
cc: Dr. C . B. Jackacm
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TO:
FRGt:
DATE:
RE:

Cancer Cent er Directors
\'iilliam W. Shing l eton, ~I. D.
Scpte::iber 26, J9i7
American Blood Com:nission

The A,\CI is in need of na111ing :i ne.i liaison r epresentative to
the A::ierican Blood Co::-..-nissivn. I 3tl seeking your help in
i dentifying sooeone fro~ our ce~ber o~~ani:ati ons ~ho is
acti vc ly invol \'ed in blood banking and/ or hcoothcrapy ;,;j t.h
know]cJge of cioJcrn require.cents for patient service, cspeci:illy
as t hey r e l ate to the needs of can~er p:iticnts. I ~~uld apprc~iatc
hE>ar ing fr o::J )'Ou wi tn any reco:·.nendations you eigh t ha,·c.
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September 22, 1977

Or. William W. Shingleton
Director, Comprehensive Cancer Center
Duke University Medical Center
P.O. Box 3814
Durham, North Carolina 27710
Dear Bill:
This will serve to confirm our invitation to have you, Al Owens and
Gordon lubrod as representatives of AACI, meet with the NCI Executive
Committee on November 17, 1977. I understand that our custo:nary
meeting time, J :00 a.m., will be suitable for all of you. However,
if this later turns out to present any problem, we would be glad to
move the time back a ha 1f hour or hour. The meeting will be held
in our conference room, llAlO, Building 31. Although I suspect that
our Business can be completed during the morning, we shall hold the
room until midafternoon.
We would be pleased to have your suggestions for items that you ~ould
particularly like to discuss with the Co!l'fllittee, so we can pull
together any background infonnation that would fac ilitate such
discussions.
To refresh your memory, the Executiv~ Convnittee is NCI's senior
internal management and program advisory group . It is composed of
the Divisi on Directors, Or. Upton, Dr. Ne\-Jell and several other members
of the OD staff.
We are looking forward to our meeting with you. Please give me any
thought'.> you have on hm~ we can best structure the meeting to deal
with the matters of greatest interest to you.
With best wishes.
Sincerely yours,

Bayard H. Morrison III, M.D.
Assistant Director
cc: Dr. Owens
Dr. Zubrod
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EXECUTIVE OFFICE OF THE PRESIDENT
OFFICE OF SCIENCE AND TECHNOLOGY POLICY
WASHINGTON. O.C 20500

•I
I

September 22, 1977

Dr. William W. Shingleton
Director
Comprehensive Cancer C~nter
Duke University Medical Center
Durham, North Carolina 27706
De.P r Bill:
It was a pleasure to join you in the meetings this week
of che NCI Boa rd. The combination of business discussions
with the instructive reviews of environmenta l carcinogens
and of potential applications of computed tomography made an
instructive and stimulating time .
1 enjoyed our discussions about the centers, Bill , and
I hope that significant revi ew of the overall centers program
will be possible as the data from the profiles and the visits
are accumulated.
Best wishes .
Sincerelyj/urs,

Gilb e r ~ e nn, 11.D., Ph .D .
Assistant Director for Human
Resources and Social and
Economic Services

MEET 1 NG OF REPRESEi,TATl \/ES

Association o( American Canc~r Institutes
and
Organiz~tion Resourc es Coun selors , Inc.

Ua t e and Location
Wedn esday , July 20, 1977
ORC Offices
1625 1. Street, K.W.
Kash i ngt on , D. C. 20006
Present
ORC

Mr.
Dr.
Mr.
Dr.
Mr .

Me l Garcia, Tenneld, Inc ., Hous ton, Texas
Rufu s Mill e r, General Motors , De troit, Michigan
Wayne Brooks , ORC, Washington, D. C.
Bruce Karrh, DuPont, Wilmin p, ton, nel a~are
B. K. Kwon, ORC, Wa s hington, D. C.
DT. Clifford Johnson, Goodvear, Akron, Ohio
1-tT. Denni!- Bridge, Baxter Labs , Deerfield, lllinois
Mr. C. S . Ryan, Sunoco , Philadelphia, Pennsylvania

AACJ Dr . J. Palmer Sa:.inders, Universitr of Texas , Galveston
Dr. l\"illi am \\'. Shingleton, Duke Medical Center, Durham,
North Carolina
Dr . Albert H. Owens, Johns Hopkin~ University, Ba ltimore, Maryl and
Mr . H. D. Putney , Fox Chase Cancer Cente r , Philadelphia,
Pennsylvania
Dr . Gordon Zubrod, Un i\'ers i ty of Miami, Miami , Florida
The follo\dng statements are excerpts t aken from my
notes of th~ meeting and a s · such do not constitute mjnutes
of the meetin g , but a r e my recoll ec ti on of the gist of the
discu ssions . Obviously, the re a r e errors or o~issions which
should be co rr ected or suppl emented by othe rs .
OPENI NG RE)tARKS

Mr. Brooks refe rred to the concern by industry about
the cancer problem - that "the c a ncer problem is the workplace" - and industry's desir e to moun t a research program
to study the cancer problem as it impinges upon or affect s
American industT)' .

Meeting of Representatives
AACl and ORC
July 20, 1977
P:t g<" 2

Dr. Shingleton responded by g 1vJng a brief resume of
the history of the AACI, the impact of the National CanceT
Act and the development and role of cancer centers i~ t~e
National Cancer Program. He also described the Enviro~mental Carcinogenesis Conference at Houston in January 1977
and stated that the proceedings of the Conference will he
published . His point was that the Conference had evoked
a genuine concern on the part of the MCI and that th ere
was a consensus of the Association that it might play a
role as a catalyst in the development of a program for the
study of environmental carcinogenesis between the FcdcTal
governnent {NCI), industry (ORC), and science (AACT).
DJSCUSSI O~
1.

The Right to Publish

In ans~cr t0 Dr. Saunders' query concerning the
right to publish, various spokesmen {Or. Karrh especially)
from industry cmph~sizcd their willingness to ensure that
this privilege be granted. They felt that "industry would
want the right to the information first - that industry/
management doesn ' t t,a.nt to b e surprised." Further, all of
the representatives emphasized their convictions of the
"right of the '-Orker to kno\\·" and the ramifications of the
Prjvacy Act which could present a problem vis-a - vis dissemination of medical record information. Concern wa s expressed that oft time s the rC' is a need to know the name of
the indi v idua 1.
2.

Union Relationships

Unions need (or will ha ve to be brought) into the
picture early. There are, no~evc r, diverse relations hips
which must be recognized, thus making the timing for discussion with labor unions of the essence. There is a gro~ing
interest by the unions in health protection. Undoubtedly,
suc h concern is or will be a factor in conLract negotiation s .

~ccting of the Represe ntativ es
AACI an ~i URC

.Tu 1 >' 2 0 • l 9 7 7
Page S

Ho~evcr , the representative from DuPont advised that their
rel a ti onships with the local unions dictated that their procedure ,,ot· ld !.,e to deal directly with the employees and then
inform the unions.
The same procedure would large ly be follo~cd in the
ru bber industry where, at Good)'car alone, the re arc JS plants
involved. General Motors, on the other hand, \i\euld seem to
prefer a no r e direct approach to the union.
3.

Peer Re,·ic>w

The lJestion arose as to whether AACI could peer
revie~ itself. The genera l consensus was that it could,
especially for scicn~e and technical review. Ho~evcr, there
arc s e~=ral levels ta consider, as follo~s:
a.
b.
c.
4.

Technic a l
Political
Duplication .

Po licy or crcd iLability r eview

MCI Capabi.11 ty

A profile of centers should be used as a basis of
resourc e information. Approval for use of such materia l must
be obtain ed from the :--;r.r an<l each respe c t ive institution.
:>.

Approaches

a . One proc e dure for conducting the resea rch programs would be to utilize the ta s k force approach , i.e., a
lead institution with a progran director, assisted by a
committee of experts.
b. It ,,as stated that the AALI is the only group
that has the capability and/or creativity for establishing
a data base as would be required for such a program.
c. The ORC could serve as the clearing house for
industry in that it deals with the American companies that
are most concerned with the issues.

:,.;,,rt ing o( th(: Rcprcscntat h·t•s
AACl and ORC
,July 2 0 , 1 !l 7 7
r.-ige 4

CO~CLUS IO~
1.
It was a gre ed that th~re appears to he good reasons
th~t the ORC and the AACI could s e rv ~ as the basis fo r the
developmen t o f studies of mutu a l be nefit in the area of environmen tal c~rcinogenesis.

2. There ~ould have to be dr af t e d a d e finition of the
critical issues to serve as a hasis for further di scussion.
r ~r the ORC o r indus try, problems r equiring resolution s hould
be defjned. Among these were:
a.

b.

c.

Carcinogenicity of compound s or agents
Data hase
De t ection

For the AACI, Jikewise, a corollary defi nition of
issues shou ld be deY e lopcd in t erns of:
a. ~hat ncc~s to be done , in t erns o( acquisi tion
o f kn o~ledge about thP diseases of cancer , or,
b. What areas of in ves ti ga tion or control arc
not being adequ a t e l y pursued , that by so doin g wo ul d be
of value to th e cance r problem.
3. It was agreed t hat both par ties would pursue these
natters and th at a future meeting would be he ld in the f a ll
of 1977. Meanwh i le, in September 1977, ORC wou l d conv ene a
meeting of 26 heal t h di rectors to study these cr itic ~l issues .

Respectfully s u bmitted ,

H. Donald Putney

lrnc.
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August 22. 1977
MCI int c ra;;tion with industr) in envir onmenta l car c inogen esis

EJ.-nl ~ . ·.,,, ...u u. F'U.:l.,
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Further discussion::. hav e tak en pl ace " i th Mr . K,)'ne Brooks of
Organ ization Resources Counse l or s, Inc . in Kn s hin~t o n, D. C. , a n
or gani zation wh ich rep resen ts appr oxi"lat e ly 60 l nrge industr ial
c oncerns. \;e 3r e in the p roc ess o f s ubmit t i ng a l ist o f res.c.a-rc h
pro j ects in environmenta l carc i no~enes i s ~hic h c ~ncer c e nt e r s can
u:idertake i n the i nt er e • f i11J 1s tr)'.
80..\RO OF OIR ECTO RS
Albfft H. 0 ~ t-el. Jr . M 0 .
- Ou_w-r- , n
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Oh• n H. ~b,-i, M.0 .
Rc1. "" ,,.._ ... ~l '"'12r~: ,

1 ~-ould lile f or each u r you to pleas e infor m me of the areas of
research related t o cancer ln indust ry in l-hich your centers a r e
interested. This can inc l ud e cpid c~i oJn~ica l s tud i es , basic o r
c linic:il s t c..!ies a nd other rcln t C'<l s tut! h.:-. . I \.'Oultl ·,iJp r ec.:iatc
heari ng fr o::i you nt }·our c.-nrl i est conn•nicnce-. Thanks a nd bes t
wishe s .

R. L« ~ rl.. , M .O.
ll<>ttr::,-,,

rr~u•
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Qannault Jackson, M. D. in cba.rv• of our
Extramural P1"09ram (includln9 " blood•
relaUoa■) l■ a bematolovt■t •
He could be a fine repreaentaUve of AACI (aa
be also la a 9ood nevottator) on the ABC.
RLC

R, L.EE CL.ARK, M. O.

-

,

AUCJU.lt 9 , 1977

Dr. Wllllam Shtngl•ton
PrMldeat
A■aodaUon of .Amedcan Cancer lnaUtutea

D uke Comprehenaive Ca.acer Centm
Duke Unlvwaity MecUcal Cental
D..-ham, North CarollM 27710
D ear 8111:

1 bave ,_d Nat 8-lln' • letter a ■lllDQ to be reu.v.d a ■ Met repreNDtaUve
to the Amertcan Blood CommtaaJon. I beU.Ve that hla requnt ta ln order
•• we rnaat ha,,. a repceaentaUft who la vitally laten■ ted ln the problem
ol blood procureaent f« tbe canoer patleat and la able to 01ve of hla time
to ably ........ tbe AACI. The blood ntieda of the paUero undal9olng
tnetmeat for ouoer baa now be001N one of the major u■e■ for blood.
Doct« a.11n al■o que■Uons om parUclpeUon ln paylag daea to the Allartcan
Blood Commta■lon ~BC) • I am fJnnly oomrlnoed that we abould be in • ,oattlon
\.t') provide the ABC lnformaUon relative to our need• aa canoer lnatltutN and
help ■olft the tapa■.. wbJch . - m■ta between tbe Amencan Red Croea
and the Aa ■ocJatioD of Amstcan Blood 8anka. ln a vital 11tuatlon aucb a, thia
it la umt..tandable that the ABC wiabe■ to obtain aome type of operaUone 1
oouenaua. Tbwe are many thin;■ lnvolved, howeftr, we are baalcally
talking about money aad t.rrttodality.
In oonclualon my own feeltng 1■ that the AACI should parttclpate ln the aoluUon
of the blood procurement problem which la v.-y vttal to u.. By aendJng a
repreMnta.Uve to the ABC we are alao ln a poaiUon to negoUate on our dues
to their cr-Jan1zaUon. If you wl■b, I would be happy to di■cuaa the eatabU.h. . ., of a panel from which we could draw a repnaentadft who, aa menUooed
before, la truly lntenated ln the problem and could well repnaent ua at the
meetln9a ..

Slncerely youra,

RLC:Jh

R. LN Clark, M. D.
Prealdent

N
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Can:::er Cen~er
nurr.a.'1, ~'.or:"' Carolina
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Last ::ear, Al 0,ens askec! re if I would ti'ke tr.e re::oor.sibility
for bt-:.ng the liason Rer.ber for the AFerican Blood Co:-:-- i.ssion froi, the
..\ssocia~io:- of Are'!"ican Cancer Institutes. I reg-ret Yery r.:c.h th.'lt the
c.e.-.a.-:.c.s. on -· tire haYe beer. such that I haye na4: been able to <lisc'!:ar(!e
full-.- r:v r esr-0".Sibilities to tlie .'\...,eric3ll ~le-ex! Cor.i.ission. I h.n·-:also· '>•Ti~ten· serar ately to '""d ':irar?.d sugge3ti.-..; that the d..:es that tJier
n:-,.·c c.hargec our )ssocfatic:-i appear to be la:-~e, ru:e sur:..,~este-d ~l-..1.t he
put t~.at on the ag~enc.a , \-:hether ,,e s!lould p.? rticipate.

•

=c

I ,:ould also like , at. this ti ....e, to ask yet: to
:-clj4;-,·ed of ir.v
r~s~~~si~ilities to trc )reric:m BlooJ Co~ission in representing the
'.\Ci. l fir..J that I r.o longer r.a\·e tr.e ti.~e to do r-an'\.· of the things
,.-cu!.J l iko t o do , ar:i rmst begin to restrict. l';)" t i..>;e .

~;1 ·,, 1 'P,!"l'1~n s ' !. II
Dir-.c::C''" , Cwcc.r Center
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'This is an item we received during RLC' s absence for
Surgery - I referred to RCH - who lost and sent them
another copy. I called today and Donna said RCH
was not going to do anything on It that he had talked
with Shingleton several times and was going to the AACI
meeting - I told her this wasn't regarding that meeting.
She said RCH did natJiaQnothing.
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TO:
FRO-I:

DATE :
RE:

Cancer Center Directors
William W. Shingl et on , M. D.• President
Apr il, 1977
Repo r t of the Intrainstit utc Co~mittce on Cancer Centers

Ros-II Par/It \!rrnor.al
lt1St1turt
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BOA RO OF DIRECTORS
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The Board of Di r ectors of t he AACI have approved the action of
submitting a spec ific organizational response to the repor t of
t he lntrainsthut e CoCllittee on Cancer Cent ers . A copy of t he
r eport is enclos ed, with comments made by Dr. ~ei, ell in the
margins . In order for our response to be compiled, we are
r~questing all Center dir ect ors to r eview the report and t hen
forw.ird your comr:1ent s to me. Dr. 01.cns , nr. Zub:-od ar.J I wi 11
then prepare rccor.:..r.iendations to s ub~it to Dr. ~e~ell anJ t he
Xa t ional Cancer Advisory Board Subco:n::>i ttcc on Centers.

It would he i:iost n.pprcciatcd if your revic~,r ..:ould he sent iv r..e
at your earliest c onnmicn~e, and if po::.::.iblc, no later than
May 10. 1 hank )'Ou vcrr rnuch for your assistance in this crucial

area.

u-., L eo,,..n, •,1.0
Camdtn, ., ,... /ll'ky

Chui.-. A. c~•ns. \I 0 .
~It~. >I.IY\.~,:: t>"

G. O,nm.an Hlft'lmond, M.O.
Los An9"ld, C../,fo,n,a

He<vy C. P1:01, M. O .
i::.1 '-Ott. th1.:o ,,.,n
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G. Denman lld1111nond, M. D.
Associate Dean
School of f1!?dicine
Director, Comprehensive Cancer Cen ter
University of Southern California
Los Angeles, California 90033
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Dear Denny:
Enclosed is a copy of a memorandum from Tom King to r;:e in which
he transmits the report of the lntrainstitute Coir.mittee on Cancer
Centers. You will recall that an unofficial version of this r eport
was discussed at the last meeting of the l{C/\8 subcorrauittcc. Please
note Tom's cover r.:emorandu1,1 and also ray comments in the margin. I
Imo.,, you have thoughts of your o~m ai)out this,and I look f01·1·1c1rd to
having them either at the next NCAB meeting or before.
l am a 1so sending Jona than Rhoads ~ copy as ct,ai nron of t he r:CAO.

Hith best regards for t he Uew Year.
Sincerely,

Gu/;:---;;;;J;,

M. D.
Acting Director
Hational Cancer Program

Enclosure
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Report of t!1e Int-rair,stitute Corr.:nittcc for Cancer Centers

I

no pleased to forward to you the report of the lntrair.stitute

Com.-nittcc f or Cnnccr Centers . 11:wini net 10 tir.cs !.inc~ Jun~ 30, the
Col!Q_!.ttee completes its rhnr~c with the suhmission of the att.iched
report to the Director. The continued coordin.:ition of the C.inccr
Centers Pror,:-.1L1 vith all other 1;cr ccntcr-rclatcJ pror,rams is the
rcsponslbillty or the Associate Dire~tor for the Cancer Centers Program ,
3.2.1 (p. 9). During th~ course of its dcllbcratlons, the Con:mittee
focused on the following quc-stions:

1.

t:hat is a Cancer Center?

2.

Is the Cancer Centers Pro~r.i::t a "p=ogran," a "resource," or

a "funding cech.-misr.:?"

3. \.!hat arc the r e::;ponsibil iti.:-~: of t.:CI and cancer centers to
each other?

4 . Where should a c.:inc~r cent<!r be loc:itcJ and wh:it is its
regional influence?
5. What should be t he r,>lc of the NCI Cancer Centers Pror,r.:1."11
managc:.:ent and "'hat arc the organizational parameters vithin wl•i;:h
i t operates?
In sub::iitting the report , I would l ike to call your attention to
certain rt>cOt:.:!lcndat ions which could cause problc::is and "hich 1'!er it
your critical attention.
l. 1.1 (p. 1) :ind 3.1.l (p . 7) - The inclusion of :i c.:inc er center
suppcrt (co re) r;r.rn:: (CCSC) in NCI'~ prot ra, ""l."ltic d c, finitio n of a c :lnccr
c enter is no :: n,·:1nt to c•qu.:itc a n:cch:inis,, o( suppo rt \t i.di nn i n!': Lilutio :1
Lh;1t is conr..idc rc,l t n b<: .1. l::IIH'r•r ct·:it c r. It j~ :.i1~r,ly a 1:n tlc· r Cl( (ac 1
that the ch n ·;,ctcr .i •:t l c :: \Jhl cl, r ~,ke fo:- "ccnlc- r11<:~.," :lrc e m!,odlc:I in
the? cri.tcri.1 th."lt p~rmlt such lnstilut ions LO qu.1lif:,• for a c , mcer
c ente r sup?Ort r,rant .

u

'•

. ...
2

Actint nircctor, NCt

2. 1.3 (p. 2) and 3.3 . l (p. 10) - This illlrlies that NCI core cr:int
surport will tcnniu:1tc or be sh:nply curtuilcd after 10 years. l <lo not
believe this is a c oc,d policy for ilCT. Such an attitudt! on the part of
~;c1 lJould le.id the scic•ntific cu;l!lllunity to doubt the existence of a r c.,l
cot:llllitmeut lo th~ centers prozram.

3 . 1.5 ( p. 4) and 3.5.l (p. 16) - This recom:nc:nds that the
Diagnosis and Treatment nrnnc h be separated fro111 thl.! Associate Director
for the Cancer Centers Progr.un. This reco:=endation causes a number of
p

problems within DCRRC. The b:isis for this r ecommendation wan to enable
the centers prosram (core ~nd exploratory grantn) to have a line item
budget. This can be accomplished without an oq:anizational change . I
am not prE>pared to follow throuth on this recom:.icndation before rr",kin~
:t thorough P.valu:itlon of the c:ntirc structure o( the Division of Cancer
Research Resources al\d Centers.
I would like to com:::enrl all rnc::ihers o( the Co::unittce for the ir villinr,ness
to work on this task anJ for their dcdicntion .1nd devotion . I believe
t he overall exccll~~ce of the repor t speDks to thelr efforts.

~~/

-

l_:"~~~~1 / ~
Tho1:1as J . King; P~~
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1.

Rl•:C:0:1 '11.!lll.\T I o:l!i
----

J-:XECUT i \Ir: f.llml •\Ri":

-That the followin~ de£ini.Li.cm li e ador,t~·d: For . l~:itio11,"ll
Cancer Ins titute (t:Cl) progr,,1Mi:1tic purl'ut.cs, a c.,nccr ccnlcr is
any oq:~.,ni~:::it ion.:i\ 1Jnit th.1t consol i<larc~ :i:i.i focuncs c:mccrrcL,t.e<l activities in a sin:;l\! nd:ninis trativc :md pro1:r:1m:n;itic
structure and is supported by a c ance r center support (c~re)
y,r.lnt (CC!.G). All recipient :; of this type er:int .:trc c:xrectecl
to oeet th~ following criteria:

l. established programs of hieh quality basic and/or
cl inical research;
2. a defined ope: at i onal plan to coordin~te c~ncerrelated activities;

3. a quali fied director of the cancer center program
serving on a full-time or significant p:irt-timc h::isis ;
~

.r,JJ}Y
~.IJ

4 J/.P

.
4. sufficient auton{'::l] to (ul fi.11 its pcozrmn respo11s_i~
bilities; the cancer ccntcT t.~ould be recognizeJ qS a major t~

v'

element wi thin the organiza:.io, .:.il structure of t he par..:nc institution
of \.'hich it is a pa-rt;
•

d

·
to house the center ' !: V}~J ~~~

5. adequate physic:il facilities
activities :tn<l to pror:i:>:.c coll.:tb~•ration a.nong its coustitu.::nt f:;'o-tJ.J-✓
&ramsfto ensure successful overat io11 of the cancer center;L..? )o,Or' . .~f
--.:I • j)
6. an fcst :.ib lished mecnanisr.1 to ensur<Dadcquate planni~g
and evaluation~ the cancer center ' s programs .

,--1

JI)

JY/'

1.1.1

Types of Cancer Cent ers

--That cancer centers be catego~ized as foll ows :

1
t

,1 { (1) comprehensive, where l ong-terr.1 mu ltidisciplinary programs are
111
v"
conducted and r:ieet the 10 characteristics estab lished b~ the llationa l

,..'~12,,

t

Cancer Advisory Board (::CA5); (2) clir.ic al, whc rt: cliaical research
o!C
1
,.. nd cl~raonstration proj!·ct !:; arc .ivailablc and when~ "b~_E" or "basic';
~•
1
resea rch 1J :iy or ciay not b e done , and (3) fri"o3-cli:1icin!.J \.lh \!rc Cb~t-r~·A'
e rnph.isis is on "bench " or "basic" r <!searc)F: (The se three catcgorie~. (i!Y1 •
arc not intended to il"ply t!-irei.: different types of CCSGs . All
"'/,~;), ki..,"'fZ;/.\1'
c:incer ·centers ,.;ill_ be supportc,l uy, as far .,s possibl e , a sin1;lr,,.,jv;J~O ,. . ~ ~J;
CCSG award .)
()/ 't JJ,i
.,-fr-!,•

~-ri_;l,

I
f

tl
-

i
~ j
,;.J

(jj\ l

.,..,'1

.foJl

~

I

(fr;f'J:I'

--That, except for cor:iprchensiv~ c:inccr centers, NCI µr_
.
.-,-- . ..,.,
~~
will
not officially recoz:iize or d esignate cance r centers of any
other type.

w;A,VF'

•

'
1

l

!. .
.

2

.1

11

1.2 Is the c.,nccr Ccnt,..r!: rror.r.un a "l'ror,ram,"
1-·undin?, }!,.:ch,rnis::i?"

.i

"ltet:C\urcc, " or

-That the Ca ncer Centers Proeram he considcrrd n "proz r :w1"
· Ly ?Hll <l<>(iuition to iaplc1;1cnl the 11cc,~ss:1ry cc,c,r,lin.:itjon , pr,,ct·tl11 r.il,
iuform3tion , nnd evaluation functions that will m3ke it a valu~blc and
useful resource to other eler.1cnts of tlte ifational C.inccr Progr,.:im.

&'

llS

£~
J
oJ"' .

-That the Cancer Centers Program be cons idered a re source
is .my other progr.iru or project eligible for IICI funds.

-That the Cancer Centers Program prepare a plan with 80als,
lobjectives.- and mechanisms to evalu:iLe and ililplement it,

~

~ • t,\JI.Jt.w, ·
;Jc1

1.3

What are the Rt"'Sponsibiliti~s of NCI :md Cancer Centers to

>I ibch Other?

1ft "(i'~
r• ,Y

,~·.c1,

-Lh-oug~,
~
"CCSCs, be responsible for creating a climate
for institut.ional st~tbility. Present support is liciit cd by hw (National
'\
Cancer Act) t o three-years. This tir:ie constr.1int cons m:ier much cancer
center s taf f.effort in application preparation and Rubmis s i on , and ttCI
staff t ini! in revic:.1. 1"his problem \JOuld he ,'.llleviated by l eng then in~ the
,.~fa { CCSG sup;:,ort fro::i three Lo five yea rs. Akhour~!t tlCI a ssumes n:sponsibility
VO
for pro'\·idin•. ins titution:il st,"3hi lity th-rour,h CCSC .J\,'.?rds , limit 2d
rc~ources n e cessitate that cancer centers be c:nFouraged to gradually
oth.:r fundinz; sources for s•J~taini'r! core suppol',. Thi s i m11lics
1
,• ,.
\ th;:it tiCI c;mcer center SUj>port through CCSC:s gradual l} dcc·reases as the
,.~
cancer ccnt!?r bccoc:cs ciorc establishe d .lml stilhlc: . .
. _,..
~✓-1-Hl.,(,,l;a /r~t ~ ./u-A?A✓ &-7-~w;J-J;-;,-~.-/.,nV/ o!:J- e~'--2. ~-A-(-~ .
I)
0
" --1'hat in~tifutions who foster the deve lopment of c.:ince r
centers sh:ire with ;:er the resp~nsibility for canc e r center stability.
To achieve this, t ~e fostering institution shou l d rnake · a long-term
co.ct~~t~ent of resources. space, services, and personnel, and should
~~rn~ke every attempt to achieve self-sustaining stability for the cancer
center over a 10-year period.
_·
.
-That

~

~fJ..

·rf:::c-ck

'-:iJ

LJ-

l

-That NCI not e~pect 211 c3nccr centers t o be cas t in the
Ssaoe oo td. Each should striv.:- to mee t specific conditions of clinic,11
~xcellence and regional involvement appropriate to the individual
canc~ r center capabilities a nd its s cttin~ . This i cp lies t he i ~por tance
of ide ntifie d 1;0.lls and objectives for i nd ividual c :mccr centers and the
n ,~ed for pl:rnnin.; in eac h c.,ncr·r ce; tcr to achieve it ~ objectivcs~f/~ ~vL
• •11-tv- t,. 'f-.Vvf- D-1~ 1.J.!!,; UC p .
,.JJ, "{
.11-That cani:er centers c a nnot be and should not b e favo red
~ reso urce s or receive prcfert"? ntial fundin;; trcatr.1en t in c o1:1pe ti:ig f o r / ~ ~ ~
· ::f
G)rogram resource~ T~ey should be. subject to the s.:imc peer r evi e w ~,.,,.,:-4 •
~
proce!-s as other a;,pl1.ca11ts co1~pet1ng for tlCI support funds.

0

...
centers should coo1.•·r.it e viLh m1<l utili7.o.? qu.ility research resources
1_~~
th~tt alrc.idy exist in the ir r c r,i.ons and concentrate development effort:; ~.v
on needed c.ip.ibilities not pccsc.itly av.Jilab le to th~111.
.
,Jt)
(j
--Th.it c:inc.er c e r.tc rs, as :i pro;::r :1:n resource, he responsx'vc to
specific NCI proera1:1 nt.::cd ::. in ar~.,~ \.•hare Llic•y have dcmons tr:i.tcd/quali.fic ations and c.ipabilitic s. Bot h cancer ccntl?rs a nd NCI should r e cognize
,c,J., he need for flexibility o f choice with reg:inl to the ba l ance of
.
~ ctivities each c~ncer center is expe cted to .ichieve .

«~

{))ij

. .J>' {

-That NCI and cancer c e nters h ave a joint rcr.ponsibility
to catalogue the resources and capabilities of each cancer center to
provide a complete index of the c.ipa bilities of cancer centers as a
r esource to all partic:- ipants in the N.-it ional C:incer Pror,ra:n. Cancer
~ ~enters shoul d participate with ncr in developing an individu.il insti?
-~i;:-:1,c.,~~ktional profile o[ the center's activities a1vl potenti.,l to be asl,,-:-,p..-pB •
y~:~~ current ai; possible to serve as an informa tion base for _the Canccrj.J-...
. . I)
~~ • • Cc~ers Program.
•
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{:-That t:cr is r cspons i!?){ Lo deve lop and state objectives
•~
(t .l"vfc;r the Cancer Centers P~r,ra€), NCI also has rcsponsib~_sn -(/.Y.v-(
,;:{ - 'tc"'linform c.ince r• centers of lli mitations' to futur e sup;,orti'"c1nd to work ~ J1 t 't.~:.., J
• V~L,'j)r, with c.ich c a ncer center to achie ve n r.::al iscic bal.incd ~;o th.it both "tl1e J~~ C.:i'~~ , :/1. f
1
,'~AA!i-"'V, cancer cent er and !~CI can b c G ~surcd of r.!lativelr s table r.1.iintc!na nc 71 ,•.,,l.),,,1;_,,,, (
i}J' •
~ the c ancer center capab ilit y as a resou rce] With reta r d to n e w ; 10
~ ,tlt 1.,,-- 1t
cancer c e nters , ~Cl ha s a r cs :,onsihility to cxar.iioe its obliga lions ~i;b •~- ;,1,")\,!,v;.,i
• ;,,, to currently f ~nclcd cance r c c nte :-s in 1 i~ht of ?lationa1 C,:rncer rro - l/_!,: /•..,
•-•~-•,tI&ran ueeds anc! t ailor the deve l o p:l!ent of n~,w c an:cr- cent er capa·1([. r,)fl.)J, bilitics to these need s. r;cr .:i.ls o h3 s a respon s ibility to mon itor
~.:.I the pcrforn aucc .-:tnd capab ilities of cance r cc:1::c:rs periodic;il ly and
~ 'j'J/Y
to inform the cancer cent e rs of the rcsl•lts of Ches.: ~in~ing s .
,~..
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1.4

~,ere should a Cance r Cent e r be Loc ated and ~ ,a t is it s

kegion~l Influence?

. \.Ji
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-That a prim:iq• gont of the NC! Ccnc c r Cente rs !'ror,r a:J b e to
cns1:re tha t the re ,ice C:? ,tc~ t· c ~nters o f c:-ccc: llc: oce for rc!:carch i:1
clinical oncolog y for c nnce :- pat i e nts and phy sicians within t he U.S.
II That NC[ co;nprehe n s ivc .1:1d clinica l c a nce r CC;"? t c.r s con lri bute to me e tin.~
this need. Bo th ty pes of can:::cr ccnc _ _s s i1ou ld L e included in
"appropri.itc geograph i c d i st ribution. 11
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-That ?~CI,' throu ~h t he C.:inccr Center s !1 roen11., , c oml-' l c t c its
c en::. c r s I r e~ i on ..11

' JY. jfY survey of the ef f ectiveness o :' e xisting cance r
~ •r;.1, yfluencc .
.tf ~l,,1V

--Tha-t , at the vrese:-it time , cance :- cent<::"l'" S not ba con~itle rcd
,, [''focal points for Al.!.. c.-rnce r ac tivities in their "rez i ons . 11 _t.....!-"'t ~
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unless they current ly have the resources requisite for re-cognition
.ia co~prehcnsive as determined by the GCAB.

1. 5

What ahould be th<.? Role of the HCI Canc er. Cc: nr c 1·s rrn1:r:w1
Managcv.1enl and Wn.iL .-in: t!aa: Oi ~anizacionol l':1r.1m,: Lcrs wiLhi11 which
it Op<:?rates?

· ·

J'/

~

-That the Canc e r Centers Progra:n man.ige~e nt remain in the
Division of Cancer Research ltesourccs and Centers, and be he,1dcd by
an As,s ociate Director having the authority to org.:inh.e and staff the
PrograQ to carry out his responsibilities.
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-That the Associate Dire~tor for the C:mcer C~nters Pro gram be responsible for m.:magc1:icnt and administration of only CCSGs
and the u se of expl orato.r y grants as the ,· relate to the d e vclopr.iant
of cancer centers. The man:ii~ernent and ad:ninistrat i.oa of the
Diagnosis anrl Trcatoent Br:in.:h and t he Rc se.::ir ch F.:cilitie;; Br.inch
should not be the r esponsibi lity ~f the Associate Director for the
Cancer Centers Progra□.
--That the r;c1 Cance r Center·s Progr :im rn.1nc1g<'.1,mt be a
sourc~ of information .:ind prog ram guidance, there fo r <? servinz ::i
triage function to assist c ance r centers ,,: ith con tacts .1nd i nforr:iation from !{CI conc e rning oth1.:r as;,ects .:ind acti!'ities of the
National Cancer Program • .
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In 1 959 , Nlil dev..:lop~·d

:in

c~:::r.imur:il c c11Lcrs i,ror,1·:1m pnttcrncd

C\a th..: co1\cc;,r _...,( t ill'~ Clinicnl Ccntct· at NLII. Cr :rnt~ were offorc.l to
rnwlJe costs of rc~nov:it i n_b :1 c:i~cr.: Lc bed unit \1ith :i core l:ibor:1lory
for r esearch p r occ<!11rci., .J l:ihoralory ft,r r,~ !;..:,1rd1 proc<': <lurcs , ,:md

a l.tbor:itory !or the ccnLE·r dirc.::tor. In adJition, th..: ~r:1nts funded
the tot a l cost of h ospit.1li ;,;:ition and other ncccsr..-iry costs of o;,e :-ating
the unit~~ a c linical r esearch facility. The co st of <loine research
in the unit v.,s not prov i.ded by these ccnt..-?r grants; rather such costs
~ere to he obtained by mc~ns o[ research proj ect grants o r program
project . grants. ny 1961, cevcr.il of the categorica l institutes,
including NCI, bee.in providin~ grant sup~ort for clinical research
center~ . lo Lhe case or ~Cl, the c..:oters grants were designed to
provide suppor t for outpatient £:icilitics.ns wel l as inpatient an<l
r.1di:1tion th.?rapy pro:;ran s . 1 11 add ition , these c,-:nccr center gr.'.'lnts
combined sui)port for holh the cl inic.-il re sour c e .tnd th.:! rcsc .:rch
.associaterl with the fac ility into one grant .ipplicai.io:1. These
early C.'.'lncer· c~nt e r grants supported pri ~arily chc~othcrapy rcsu:irch
centers a11d r;idiation thcr n;,y cente r s .incl c.-1.iph., sii:.1<l i:1ultidi $ciplinary
a ~t ivitiei., i.e., clinical ch.:m<1thcr.11,)' with rclatr•tl pil,1rr.1,1::ol,,!;y ancl
b ioche:-:istq· or r.1di:1tion thc r;ipy wi th rclat\?d ra-d i.,t io1, hi o loz y .'.'Ind
r .'.ld i .1tio11 phy:;ics , e:::c.. ,\not\ier objN:tivc of Lh,: c enters i;ra nt p:-o gr :i.:i
in lhe e :1r ly 1960 ' ~ w.1s t ('I cnl;iq;c the scop::: of c~i s tin~ c.•, n ccr institutes . To this end, a clinical rese~rch b ~J un: ~ ~:is c:s c nb li shcJ .'.'It
t he Instituti! f o r Cancer Rc sc.Jrch and a sio i.lar u n i.t wa s :::ct u p
the
DetToit Institute f or C3nccr Rcseacch. rrior to ~1is tim~, ba th of
these i nstitutes h;id been cn;a~ed solely i n b?.s ic C(lnccr rese arch .
Simil.>rly, at the Ellii:: Fischel C3ncer ll.ospit3 l, .1 1,twrr.1.:Jco lo~:; .or.d
biochemistry laboratory v.:. :. cre,1ted to e.xp,md 3cti·.ritics into l .iho:-ator; research Iroin .i strictly clinic.:Jl progl"a:1. !n 1966, with the
pass:?!':e of che Re 6 ional Hcdic.il Programs Act , the 1:c1 budr,ct was
i ncr ease.d by $800,000 to suppo rt pl.inning grants. The s e gr.:nts provided iostitutio~s with th~ me ans co develop cancer c e nter i,rog ra~s
and nccel~rat~d the crc~tion of Qulc i dii::c ipli~3~Y c=ncer r~sc nrch
c enters . At the tirac of the signing into l.iw of the a.:itional Cance r
Act ( 1971) . Lhere w~rc some JS institutions ,~ich l1~d clini c = L research
center g r.inls. In Hay 1972, th~ NCAB interp::c c cd Se ction /,OS~ of the
Act as r equ iring that NCI cst2~lish 15 new co~pr a h e nsivc c 3nc~r centers .
GCI s t n(f wns requested to d e v~lop crit e ri:1 [ o r nuc h cance r c e nt e rs.
Orir,in."llly the st.:iff presen ter. eig ht criteria wh ich •,1..-?re a cc~ ptcd .ind
t he ~oa r d added two narc, nntin: ~ cotnl of 10. le is o f sa~c
i n::-.•rc s t th:.t. , of the l S co~vr c!1c11:::ivc c a,~ccr c c n::.:r s H!1 ich h :ivc be en
r cco.;n i zc,l by 1:cr , :ill hut one ( Ohio Stnlc Univ.:ir$ iLy), h:1d 011c or
1.1orc c \ inicat rcsc.arch center i;r,mts, program fH'('l ject r;r:ints , or
p l 3 n nin~ &rants vell b~ fore the passatt.: of the 11:itional Cancer Act.
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2. 2 Scope :md Pur po~c of the NCI J11t·1·ni 11st it ut c Co111111i t t<'c for
Cancer Centers
Th~ scope .ind purpose of the Intrains tit11te Committee f or
Concer Ce nter s was t o prc1111ut c a bet t er undc:-stan<ling of th e Cancer
Center s Pi"our.:r:1 act ivit i es .ind to .,c hiev<' a better r c l :11· i o 11 ship \11th
all NCI protr:ios. Thi!': Com.:nit tcc consider ed .·uca::: of concen1
throuehout NCI \.•hich involve d the Cance r Centci:s l'rogr.,m. Issues of
interest to other ~CI prograi:is \.ICre also di :::cu!'.SN1 • The:: Cor.1mitt ee
was charged t:o prepare a • report for the Di.rector, nat ional Cancer
Pro&ram/!1ational Cancer Ins titut e .
M:my issues vere identified and dis cussed by the Committee
in the frc1tue work of the following questio11s :

- ~'hat is~ c~nccr c e nter?

- I s the C:inc c:r CP.nters Pro&r.'.lm
or a "funding occh.1ois·m?"

A

" procr.:i:a," a "resource," .

i

i

-tfuat are the res pons ibilities of NCI and cance r centers
~o each othe r?

-Whe r,~ should .:1 c.lncer center b.:! located :ind what i s its
r c&ional influ~ncc?
-m1.:t should b e th~ role of the :{CI Canc e ::- Centers rrog r ;:ir.i

11

~

i:

s:i~oa gemcnt .ind \.h at .ire the or3:in i z.'.lt i ~n.1l p.ir.imetcr s
within l.•hich it ope r a tes?
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3.

ISSUES ,\NJ) RF.COM~lr::mA·n o:::;

The l ack of <lefin iti.on of :i c;mccr c--=n t ~·=- li:i:. l e:d to
cons i dcr .'.".i!>lc confu:; iun it: t.:r .1 s \l.?ll as in the o u t:; i ~!I! r.ci\.:nti.(i.c
and lay c or.ll'lunit i.cs. The d ,.'.'· > i o n rm·. t .:id<'ly .-icccptc,I hy both
cem!>c rs of tlCl end the sci<: :: i fie or.-.un i ty is th,H ., cance-r
cent.er is any entity tha:: i fu11Jc . (:--ur.1 the "c.-,,.ccr center s progrm:a b udget ," which i s pl? r c..: v..:d ' ·-' include all C.CSGs. pro~ r.-i:,
project &rants , and exploratory crants. Use of chis d e finition
vould indicnte t hat t here w~r e approxiQutely 169 " canc~r cente r s''
funded by :icr ir. F'l-75. So--a.? i ndividuals ~i ::hin om:;.; , tan, m:a, G,\O,
and the scientific co::::iu:-iity h.:ivc :.issun~rl t ha t t l,e bud·:c t for t h.:
C:inccr Centers Pro: ran $t:pports the t nt:1 l .,c tivitics of a " c.!ntcr , "
such .is planning, CCSC sup;,ort. con s t rue c ion, r csca:-ch p:-og:Jai
support, and educational :i.~d de~onstration pro~r.-i~ support.
Such perccp:ions do no t distinzuis h between t he costs of
dcvcl opin& ~nd o~ict ainin; a caac.::r center (CCS~) and t he c ost;
of su~1•1.> r tin~ c o:::ipont'nt p:-01:r.?os of th:..t c.inccr cen t er (c . r,. ,
rese.irch , €!ducation, nt!d dc,-:oostration). Therefo r e , any intt?rpr.?t:ition or de(i~;ition of tLc c.:m::cr centers concept ll.i::-cd on tot.:l
budget will lead t o .1n erronftous concl us i on a s to the actca l co~t
of cst.1~lishina anJ n~in::aiuin: cJnc cr Lcn::er~ . Cle~rly t he total
out put and i mpact o( a c .. nc.:r c catcr r c l a c~ s t o its t ot:i l p r oi;r.,::i
:ind ·, thcrc(oro?, its t otal Le l~•!t.
!!J•~·c ,·c-;-, the cost of cstah~
lishiog and n ain t .iin i nz. :? C.Jncc~ c e nter r.:?l atcs only to t he Sll,>;>Or t
of its "core" ac ti'lities , soml! plan:ling funtls , anJ in sowe cases
cons truction support . Th~ Gcfinition o( a can~.::r cente r should
take this into a ccount. Al so , it i s il!lp.? ra::i\·c that ., 1:iorc cle.:ir-J
cut ~nd support able definition of a cancl!r c ~~rer be developed
which can be usetl by r:CI. staff an<l the scientific and l.:iy
co::i.::iunities .:ind be under stood by all.

3 . 1.1

Reco~~endnt i nns

-".iha t t he followi.ni d c {i ni.t ion be adopted: r'nr
1;c1 progr ar..natic p1:r;1ose s , ~ c ancer c en t e r is .·my orz;-mi.7..1tion .1l
unit t hat consolidates an<l focu$ ~S c a n:: e r -re l ~l ~d activ ities i ~ ~
cinr,lc .1d.-:;i.11i.stra t ivi.! ~n.1 pro~;-J :i., tic -: I r:;ctur,• :i:-t..! i-: !:ur•po r ::t'c!
Ly a CCSC . All rcci1,i ,:-~1 t :, t,f thi~: lyp:: r,r,,nl ar,' .:.~;,.:c Lec! Lu 1:i,::..: ::
the fol lo~ing critcri.:i;

1- est.ib l i $hed proicar.is o f hith qu.:i lity b~sic
tmd/or clinical rese.:irch ;
2.

a d ~ f inc,.1 operational pla:t t o coon! i n;i t~ '

c nnc c r - rcl atcd activitie~;

L

l;j

!
l

8

l •
program servinz o n

,'l

.t qua li f ied diccctor of the c ancer center
fu ll-time o r :;ignificant part-time bnsis;

...

suff icient .iutoao1.1y to ful fi 11 it s pro~r.11:1
cen Lc r sho~tl d Le recogoi7.cd .:is a
ma jor clc=en t viLhin the or~Jnizational structure of the pnrcnt
institution of which i t is a p:irt;
I>.

r e!>ponsibilit ics ; t h e

1

C,11\c\!~-

l

I

I t

5. adequate physical faci lities t o house the
center's nc t.iv i ties a nJ t o 1>=01.,ote collabora tion .imon~ it s constituent
progr.-ims to ensure successful operation of the cancer center;

I1
I

•

lj

G. an e~tablished mechnnism to ensure adequate
planning a nd cv:iluatiou of the cancer cent e r's prozraas .
-That cancer cente rs be cat egorized as follows:
( 1) c omprel1ens i v~ • "'her.: loni-te-rc1 mu l t idisc ip lin:iry t'rocc-;:i,:,s .trc
conducted .:ind 1.:ect. the 10 cl1aractcri,. t ics es tablishc,I by the r;cAU ;
(2) clinical, where clinical r esearch ~nd der.nnstration pr oj ~cts
a1.·c availn~li! ..snd where "bench " or " b.isic " rcscnrch m.:iy or m.:iy not
be done , .ind· (3) non-clinic:?], ,...here _the er.1phas i i: is 011 " bc ncli " or
11
ba:;ic"' rcs ~a rcb. (Tl:..:s e three caLcgc,r i c!. arc not i nt<!ndeu t o
i mply three different tyr,ei: of CCSGs . All c.'.lnccr centc::-s will t,~
supported by. as far .is poss ible, a singl e CCSG awnr d .)

-That • exc ept for coi:i :,::-c:hcnsivc cnnccr centc n; ,
t CI wi ll not officially recognize or dcsign,tc c anc~r ccnicrs of .tny
other type .
3.2 I s the Cilncer Cc ntc-rs Pr oir :im a "r::oi r;.:n , n " Rcsou::-cc, " o-:"Funding x ~chani sm?''

.-i

tHH d e veloped the follo-..,ing definition o f a proi~ra:n •,.hi.ch was
utili zed by NCI in Aut:ust 1971• in the 1:;itional Cancer l' r ograo O:l.! r .'.1tioo.:il Plan:

A co~1crcnt assemb ly of p l :ms, projecte d nct1v1t1.c s ,
J suppor ti ng re sources - cantai~~d within an
ad=: nist r~tiv~ manac~mcnc fra~cw~rk of so~~ kind t o i ~ p l c cent ao ag~ncy ' s oiss io~ or so~e •~ccific
pro~1 ~ru-rc l ~tc<l a~ pec t of t~at wi ssion.
2

A p rt ..;r:u:i s hould h nvt: one o r mo:- ~ of t he fol lo\li.nz
l!ttr i t.utes : ( l) c lea:-ly d,:fint:tl .incl ~peci [i ed
objc~ tivcs o r purpo~es w~icn arc discrct~ and
a c, ..:pt .:ib1e as ,111 end t o be out:iinad; ( 2) ::: c p."!rate
1tcm identification in the annual uudictnry pc-occss ;

1
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('3) distinc t orr,,1nb:ati<Hl,'.ll s tutus by virtu•! c,f
its u:ir,nitu~lc an,! s ii;nifica'l\cc; (4) ;1ctivitic•c;
where there is a clear-cut process o( managin~
nnd direc tinc ~ g ive n set of ope r ations , Rt~ of
1:1on~y , or staff to ;1cco1.11'lish sv,·ci.[ i.cd ob j cc tiv('s
or put'p<>s~s.
h rcvie,;, of c,1ny other definitions, inc luc!i n~ the Nlll clc fi r.i tion, sho~s lh~t any organizat ion.al activity to be conside red n program
pust contain certain key (! l eccnts which .. re: ( 1) ;,lan \lilh clear ly
defined objectives; (2) separate budget .iry idcuti.[ic a tion; (3) di!itinct
orcanizational status; ~nd (~} clear-cut proc~ss of manazing and
direciing to accomplish specified objectives.

The concept of the Cance r Centers Progr:im as :i reso urce is not
in conflict with it heinz a pror,rao . "Pro:;r:ims" arc or .should be
im?lcoc-nte<l t.hrough a v :ir i c ty of "fundinz .::icch,rnis:nf. ," i. c. , cou::r.lcts,
individual investigator gr.ant s , program prajcct grants, CCSC ~r .lnts ,
etc.• d e p e nd ine upon the sci t.!nt i (ic proir :m ncecl:;. An i mport.'.lnt
f.1ctor exa..':\ in11d by ~ ite visitors is the quality, nur.lb.!r , :ind d.i.v..:rsity
of su~?ort the cancer center oLt.i ins in .'.l COQpatit ive f ashion. This
YOulcl > th~r,: fore, iaply th.it more th:m one type of funding r.1ech<?ni~r.1
is .issociat..:d \lith a cancer center.

•
-Th:it the Cancer Centers Ft)gr.:1r.1 he consitl..:red a
"rro.;r,'.lm" by HIil d efinition to inplc:-ian t the ncc<'s_:..:iq· coord i n:tt ion,
procedural. inforoation, and evaluation functions that will w.lkc it a
valu.ib l c and useful resource t o other elcacnts of the 3ationa l Cancer
Protrza.

-That the C~oce r Centers Progr.a~ be considercl a
. resourc e as i.s any o::he r proirnc or project e l ig i b l e for NCI fonds.
-That the Cance r Centers Program prepare a plan
with &031s, objec tiv es , and raech.'.lnisws to evaluate and i op l c~enc it.
3.3 Wlwt arc t hi? Respo nsib; litic:i:.
Eac h O::h c r?

(I[

NCI and C:mccr Cente r :. lo

17
I l
l .
I

At the present tir:1e , of the i ·1sti::utions recci·,in:; CCSGs , 18

h ave b een rcco1;nized by llCI ns com;aclt,lnsivc cauccr cc nt.: rs . Thi?
rci.1.1in.Jc r h.:iv..: div~rse c.lpabi l it i es , so1::a in bas ic l:al,oratory r.:s~arch ,
som~ in m11 lticiisciplin.iry clinical re~c.1 :-ch; soi1c h.'.lv..: looth l ::il,o:-atory
and clinical research c ap.;b ilities, l-hil!.! others have sp.:cializcd
clinic ~ l research capabilities , such .is radiation oncology. Each cancer
cc ntc- r has a co:n!>ination of f.1cilities, sta ff , rcsourc-es, and capabiliti~s unique to that cancer center.
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Collectively. all the above Lypcs of cancer centers .ire a
n.itional resource (or th,~ .1cco1:ipli:.h:a.:nt of the scic>r1tdir. effort
needed to ~chicvl! thr. objeclivc-s o[ the lfati.on:il C:inccr l'rot~r.un.
Chat'acteristic~ p:,rticul.irly import.mt (:.dthou~h nor ncccss:irily
uniqu.::) to cancer center:; in this role .:1& .i 11.ition:il resource
inclu<le the fo llo•.1in!;:
1. Cancer centers can maintain :i critical ~.IRS of staff
with .1 v~riety of clinical and basic :-:ki 11:. \.'hose abil itics c.1n be
:ipplie:1 to specific cancer research .md :1pplicat ion projects• and
develop facilities .ind supporting services to facilitate oultiliscipli_n.1ry res~arch and tr:iinin&;

2. Cancer centers have a primnry com~itaent to the sing le
disease. cancer, and to the o;,erall cancer prol,lc:o. ·fhit. commitucnt is an opportunity for c-ancer center:. t o serve ar. a foc:il
point in the community for :lSpects of the c.:mccr problem. This
".ikes the~ a valuable r~sourcc for pro[cssional trainin~, public
education, demonstration Q( rcscarcl1 results, :inJ core rapid tr~nsfer of research knoYlcdge of patient car~ .ipplication .
These ch3racteri:.tics outline the value of cancer centers as a
resource to the :fatioa.il C.inccr Prot,r:Jo. Tuey also :.u~;;e!::L rc-s j,onsibilities on the part of c~ch individual ca~c~c c cnl..:r and HCl
toward all c~ncer centers.
NCI i:. directed b7 law and coi;,. :.iiLt cd tnu.lit ion.illy to
&upportin& the capability or cancer cent e rs to co:-:duct 1.m ltidi sciplinary b.isic and clinical rcse:irch, dcr:i~n:.tratiou of resc,1rch
results. profession~l education, etc. CCSG support has bccorac the
pri1:1.iry cechanis1n by which ::c1 fulfills iLs co.:,miti:.cn t to cancer
centers.

3.3.1

Recomcendati ons

-Th.it ~Cl, throu~h CCSGs, be re~pon:.ib1c for
creatin~ a cli::iate for institutional stal>ilit:y . Pr.;5..:nt: !::uprorc is
limited l,y law (Nat ion;il C.inc..:r Act) to thr..!c-ycnrs . Thi!. tir~c conctrain~ consuQes ~uc~ canc~r c cnler staff effort in nrp lic:ition preparation and sub~ission, and UC[ staff tine in r evic~ . Yhis problen would
be al le:vi ated by kncth1:n in:. the CCSG supp~:-t (ro:n three to f ive y~:irs .
Althouch 1:cr assut::cs ri.:spon:.ih ility fur p:.-ovidin 1; i11 stic ution:1 l !;t;:l, ilicy
thr<'u~h CCSG .iwa .. ds. limi Lcd rcso1:rces ncc.:!s :. il.:i~.? Lh:it c.ance:- centers
t,c cncour:ii..:d to ;;r;, lu.:illy sc.;k other fun,lin_; .:.vurc.;:; for i,ust:iin'.!d co:-e
cupport. 1'his i mp lic:. th.1t t:CL c:mccr c enter sup1,o:.-L throu~h CC5Cs
r.radu:ll ly decrc.iscs as the c :.mccr c.!ntcr l,cco::ies oorc cstal,lislteJ anJ
stable.
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--'fli.tL i11:1tiL111 ilm:, ,1l,o fo:,ll:r the <lcvclo1,1.1~nL ol c:mcc r
centers sh.'.lrn wiLh i;CL the- r cs:,c,n!; ibil ity fo::- cancer cent,~r st:ihi liLy.
To achicvC' thi :: • the fostcrini; inst i tul ion should m,1kc :i _long-term commitment of re::.C'lurc c:: , sp.,cc , scivic ~s , ,:11111 p ~n:onnc• l, nnd :;\1ou lJ 1:iakr> c-.vcry
«ttcm~~t to .ichi,:v,· !,c-lf-!-u::t..iinin..; !:t.ibility (or t he cance r cent e r
over .1 10-yea r period.

-Tli:it t~C[ no t eY.pcc t .-,l l c:1nccr center:: to he cast 1.n
the ::a.tle r.Hlld . f. ;.:t, di ·uld :;.:riv~ to 1,cc:. r.:,,:c:i fic conclitioru: o[
clinical cxccl l • 'IC •: :m.t r,!•.ion.11 i1:vol vc:.:-.:nt .1ppropri:1tc to the individu.-il
cance r cente r ca?:thilities end it:: sctti n>
'!his imp lies the i1.1vort.'.lnca
of identified 1.,1.tls :ind obj t'ctivc s f .. ,. i.nJivi.lual c,mcer centers anJ the
need for plann ing in each CJace r cent e r t o ., chicve its ohjectives .
-That c.inc< r cent e r s c .innot b<! ,ind should not b e
favored resources or r cc.-i...-, rrc· f<1rculial fur,dinl.! Lrcalncnt in co:npeting (or pro~~ r ru:. 1-·P .1. ,•s . Thc-y ~houl ,I he !:ul,jcct t o the s ;111.pecr review process as othe r applic~n:: s c ~,p~tin g ( or HCI support

funds.
-Re~ardinr. t echnical cap~~ ility, t hnt c~nccr centers
b e responsibl e f or dcvt:lopinc and naint:iinin~ sd c n :: ific \!Xce l l ~11ce in
their rc:.~arcit c apab ilities and rcsultr. . 1his i t::;,lics Lh,, t c;mc<·r
c enters should coop..:ratc witl, a nd utili ze qua l i ty rt: N\!ar ch resources
that alrcndy exist in their rcc i ans a nd concentrate devclop~rnt e ffo rts
on n eeded cap.-:b ilitics not pr~sc11t ly av.-:ilat.lc t c, thct:1 .
--That c ..,ncer c enter s , .:i :: a 1, roer.'.lr:1 r cr.ource , Le
responsive to specific llC[ prog::-.1:.1 nee,1s in are:is whcrr they h ave
de11JOnstrated qu.il ific:-tions and cap;,l.,iliti~s . Both c :inc-c ::- c cntt• r s
and NCI shout r ccozni..:e the n eed fo::: flexi1'ility of choice wit:1
rcg:ird to the balaac.? of .ictivitics each c ance r center 1 s expected
to achieve.
-Th.1t i:CI and c .:inccr centers have

:i

j oint r es pons i-

bility lo cat:tlC\guc t he resource:: and C.lp.i!Jilitir.~ of e ach c.,nccr

'

center t o prov i de a COO?l.!tc i nd~x of Lhe c~pabilit ies of canc e r
c~ntc rs .is a rcsDur cc to all p:i rti cip:i~:s in the ~ ~lion.i t c~~ccr
1-'rogr.ic . Cancer c e nters should p ~rticip::tc with i:Cl in Jcvc l opini an
individua l i nstitutio nal profile of t l1c- cent~r•s activiti~s and rotrntial to he a s curr~ nt as po ssible t o s~rvc as an inform~tion b.isc for
the Canc er Center,; l'roer,111.
--Th., t ?,CI i s r ''>ponsib? ~ t.:> tlc-·:.:-1-'p :i~d :-t.lt c t•~•~cc tives for the Cancer Ccntcri- Pro,;ra:n . 1:cr .,lso h.1., r csr,oasi ' : iLy t o
infoni cancer cente rs of li1'lit.1t i ons tu f uture St:?;-,o rL ;11
tow.: •. wi t h
c:ich c.11.~e l· ccnLcr to ar.hi.cvc .: rca li1, t i c bal:rnc,.: so th t b~th the c .~n::c r
center and ::c1 c.in be :issurcd o[ r c l :it i'l-·ely St ahle:? 1:1..iinr. ~:1:mcc of the

I
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~
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c:mc.-:r cr.nlcr c.,l'.ali i l i ty a:: a L·c:..ourc,• . I-Ii lh n :r,:1nl to 11c \l c.mc-t·r
cc:ritcrs. t~CI h .is a rc:;pou:,ilii. l i.ty t o ..-~::1mi.n,: i t 5 ohlir,,1t i onr. Lo
currently funded c,mccr ceutt.:rs in li&ht of N.ition:il C.Jncc r Pro,~ r.11u
ne~d:; .i!ld t .,i lor the dcvcL,1\,:,·nt of new c:,nc<:r center ,~ap:.iLi.liti,•~
to t he~.: needs. NCI a l 5o h.:i •, :i r espo.1-:it,itiry t. o r.-:o:,itor th~ p..:rfo:.-n:incc nnJ cJp.ibilitics o f c::uc,·:- ccnlci·!': r•:• ri.o<li.c:1lly :,ml to in forc Lh,:
cancer c..:ntcn; of the rc::u l Lt. o ( the:..: ( i11J ~ .:;~:; .

3-'• Where should
Region.il Influence?

:1

Ca nc,: r Crntcr be J.oc:itc: d and t..,~t 1s iu:

There is no rolicy wit hin :;c1 ci..:lit:c-::1ting the reeion--il influence ·or :i c:inc.:?r center \,hc-Lhf:r it i t. co:Jprchcn:; i.vc o:- not. Thi" Lick
of definition of retional in fluence h:is l cd l o confus i o~. Exn~?!cs o[
this a rc th.it one cor.iprehensiv ..~ c .inccr ct!aLcr feels Lit.it it i ., r .,p.,n:;iblc f or an entire St ;itc . \lhCr!!as nnothcc c o::iprchen:; i ve c .,n::,~ r ccn:...::r
fee ls resi,onsiblc: for a sci.ill set:c-.r:nt o f .'.l cit y . The c onfu:;io•, e.irri ,•s
over into 1:c1 jn that rcf,ion.:i l infl uence hJs been defined in ,,.-1ny "1:t;·s ,
such .is: (1) p:iticnts should uot h.:1ve to st:iy overnir,ht in or,k :- Lo
receive trea tr.ient at .i canc,:,r center, (2) no o,\C should be core th:m
"X" miles from a c .::ncc r c enter, .ind (3) a c.:m~er center i s responsible
for as lar6 e ·an arc;i :,s i t "c~1:1 h.11dle."
At a r cccar r.;cct i n,~ of c;incc:- ct.:ntc.::- ,!irt!c tors , it,::,:.
s ut::estcd that a co.:i?reh ·t.si\'c c ., nccr c~ntcr shou:c h-:v<' sit~n-o~:
:iulhority o r at lc.:.st c,:,:::·.1rnl autl.odLy 0:-1 ;:ny .:ncl al 1 ira,tls .1nJ
contr.::cts toing to r:cr fro::i its "rciio:1 ." 'Jti is "re:gion " \:Js to loe
determine d by the p.irticul:ir canccr c~ntcr.
The issue o! rcBion:i l influ!!ncc o f cancer cc:.ters .1p;,.:.irs to
h.sve .irisen in star.~s . "f!t~ 'larborou;,!. C(\, ,i.::tc.: re;,ort ~:illc1: fo r
creation of " • • • addition.11 c.:incer cc1Her.~ in different parts of :.l i.!
country • • • ," and sai d th-:::,- " ... ::hou!d l:.w~ :t 1 propri.ltC- gi'o&r:?;>'.1ic
di~tribution and ••• be created where a nucl~us o[ ... pcrsonr.nl a lrc~dy
exist s and pr eferably where a universtty or a c~cl ic.il school a[f~ l iaLio~
CY. ists or i s pl.inned " ( 92-659, p . 31). IL fo::tiJcr stales " . • . nc·,1
cc,,tc..- s :::!wu l d not be crc.iLed uiltu·c there \,•m:ld be ;i ditut io~ ... o(
t'x i st i.ng centers . •. . " The p,: mc l r eport c,1-'..! clc,n Lh,1t t~e cr~.:1tio:l
of cancE:r c-e::tte:rs " d oe s not ne:t:-i t hat t l,c (i!CP) is lo unc!crta;,.c ~euc r:il
rcspc,r.s ibil ity for c.1rc :1:1,I t r c.itr.icnt o( canct!r p.:ticnts " (92-6'.:.9 ,
p. 32). l~~g ..rdi ui c oordi:1.'.lticm . the Y.irhor.>u.;h p.:mcl sa ~d:

-

"Thn •.. c c:.tc:-s should
scr\'c ;,:: :tcl1.1 ini r:tra t i ve coon!1n1to :-s o( those prn[;r -,:.•s ~·'.1ich r ('qJ i.r~
rcgion.,l CC.'Ort.li.n.,t ion. ( T11c·y ) !.ho·1ld SU;')l'o1·t aml
assist clinic:. .,nd co.:i.-.m nit;- ucdic.il cC'r.tcrs in
their own r,co:-,rapiiic :ireas in or.1,:r to .i:;sur.:: the
widespre::d use of the best .:ivai l:il>l..: r~..:lhoJs . ''
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The ?l.,Lioa.,l C::tnci:r ,\l· t o{ 19/l itc .-1 f c!c,I' !- ric,t 1:l<'n Lion l occ1t: c1 n vr
c-uordi.n,1Lion, but lh•: r,· 1,-,rt ,1r co,::n11;· i:11: lhc llt,u !>•.: hill dvcs . 5i.11c.:
lhc l;1n;,;~:i~c of th -: fin,tl l:1w l.!. lru:·1 th..: l!ou r,e Lill , tin: rci,.>rt is
r.uidin~. The report ( 9:l-6~9 1 p. 2!>) st.it.::;;:
·
" The CC'r:-;:1i.ttc•· {l'E-l :; Lh.lt c:-:i.~tin;~ c::ncc r ccntcrc
thould hC' r.trc1~~Lh,:nc,I :m,: :1<lditi.o:i:1l ...
centers in different 11.:irts o ( ::hi:: c o11ntcy ::l:011ld
b e crc,,t c<l . Thr·i.c new cc•ntrr:, r.hou Id ltavc ::ppropri.:itc c co~r~p~ic Jis triLuLion .:in~ choclJ,
~,ercvcr po:;siblc , he crcat.:d wh.::re :i nucleus o{
sciclltiiic , pcolo!r, r.io11:1l 1 ::l'1d 1.ian_a &.::ri.Jl personnel already cxi~ts.

Cancer Cl·ntcr:; c.l11 pl.iy .l ..i:ijor role ••. by
(5) scrvin~ :t., foc- .:i l pciints for cc:;ti11~ .ind
evalt,.:i:.in., ou:.puts c,f the :-c;;c.:irc~, .i:, l d,::v c lopccnt c[farts •••• These {uncti0ns cnn be
c arried out by spccializcJ :is well u s cowprchen:.ivc t.cnt1.:rs."
The t l!n:1 ":ir,;,ror,ri:itt.' r.cog-r.,;-hic d i.s:: riLut i o :~" t hen nce<lcd
intc:-pn: :-.,tion. luiti:il sclt.:ctil,n;; o{ c o:.. ,,rch•nsiv•.; c;inccr ce::1l•~rs
were n.::itur.11 ,rnd f..irly easy ~ince t h<")' v.:?:-~· na;!c .,L i.1:,t i t\!-.~0:1s of
l on~:-;t.,ncl in~ undir.p 1tcd rcpu t :i tinn . C!linciclcn t .,11 ;: , they 1.1.::rc fai.rly
\.'idcly Jisperst:d r,ec,,: r ,1 1ihic..illy as wc·l l. la the s ...c.,n;J roun ~ o!' .;,c!lcctions, a con:;;cious e:f~o:t w-.i. : ;de to i~cr-:?:isc ccuir.'.lphic covcrat.:<.: At thnt point, thrl!C f.1ctors been~~ ~?p:lrcnc :
1. Conccntr:ition on c1u.i~it'y of prc-.,xist11:;- in::titutio::s ~s
t he price selection f:icto. ~-oulcl re st:lt i n &eo~ r .:y'.1i.c .. lustcri~1z , likely
including even o o r c than one cente r i n a civcn city,

2. So::ie r.wjor part:: of th~ cou:1t ry s~.a:.icJ t o l a ck even the
potential for devclopinr, a coaprehensivc c ance r center,
3. In th.:? Ga ~ioo:i l C~ncc- r Act of 197 1, the r e w:is no clea r
ratic,n;ilc for the nu ..1~..:r 15, either .is .i tar&.!~ o r .is a lira il .
'J.'iie Gr neral Account in~~ Office ini.t i ntcJ a study ·,:hich w::s
co::1plcte<l 0:1 t-:a:-ch lS, 11)76 , cnt i.tl cd Co~. r c':l.::=i!;i:.•,· C.:nc-cr C<-11tc:- s :
The ir Loc-:,tiC1ns .ind Ro l l.! in r cno11!', tr,,c10:1. 1':,i..~porc r'--co-:::.1.:!:;d<!dt hat i,C l $i\Ou l <l:
"--Uccitl,· o n lhl· ~p.:ci[ic r.,ctor:.. tha t will l,.usc.l t o tlctcr,, ir.~ l oc:ition:, o[ co.:ipt:d1t:11si.vc
c.inccr c.::nt.:r~ , L.Jl;inc in;; th..: need i o r r;cor,rc1phic <listribuLion wiLh oth.::r f.ictors.
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--Re port l o Lh~· ,1 j•l' rt'l•ri:it,: C(ln~r•·:,:. icin:11
co1:m1ittc(':: cm the· <'l.f..:.:t otl1<· r f.i r. r o r :; \.IL 11
h ~vc o u loc .1 tio11 s of c,:nl,:rs :mJ lln: feas i bil ity of achicv i.n.; ,"\O apprClpr i atc gcogr;, phic
di~tributj o n.
~

-CL,r i(y the rnl ,· of tl:c:: cc-.·-1':-chc-n:, i. vc c 1: t1lcr
~s .i foc nl poi 11 L f ._, t 1l.:::.111:1st. 1·:i::ion p:-v.:i.,. ., . ,
incl ud i.ng <:st:ih1 i ~:h i.:ii: c ri t cr in for dd.cr.-li ning
w~e n the center ~ Cd n act cficctivc ly :is focal
points."

lt shou l d b ~ rc:il i:~cd t.h:it this CAO r <!port addH:sscrl iL sel f only LQ
comprcl~ensive c;mccr c c nt ,~ rs. Thi:. r eport ha .. g c.-.cratcd a g reat deal
of co11cern 1Jithin ::er as co how l>cs t to address t._.e i ssues raised .is
to l ocatiott of a c:inccr ccntc.:r a.id the r c~:ion.;:i i nfl ue nce fo r each
cancer cent e r.

I

In .,11 of these r epo rts ·a nd tc!-.ti:11ony r, iver. before Co:~.er est~':1
.:i canc.::r cent e r 1J~)
be located b a s be en lo st . I~ rcnlity, a c a ncer c e ct~ r i ~ eoi nc to
ex i st ~he r e ~here i R a critical ~.:iss o f p~ysicia:l~ , sc ientists , pati ents , refe rra l patterns , n p;,:-o;,ri:itc l oc.11 :rnd r cr.io:l.t l 11oli.tica l
c.ircu::tstances , t~he r c the ccist of such an end e :-inn· is &cccpt.1olc , M~<l
\.111en au org.jni?.ation,11 .:nt.ily i s r.?:i.:i;- to r:,.,,mt• th u e[for i...

it .,ppe.:1rs tha t the ' 'r ea l vorlrl " ,1ttitudc of \::1..::-c

J

liCl b as- cl<:velopcJ .:i policy t~at " cunters sho1:ld have :1:,1,ropriatc r,cor.raphic.::il di s t1.·i~1t1tion to c:1su r l! r-,,n:i1.11a 1 bcn.?!iLs ... accn:i.:
11
to the 1.'.lr~ -~s t possible (rac::.ion of the U. !:; .
With r csp.::c t to ca,,c ,·r
center functions in l,.1s i c r esea rch , t.hc .lj•pro;,:- i ate g,::ot r a pli ic dis Lr i tbut i?n would ~e!!::i to_ be in_ l oca:icms i,~c:e i,,·h.:i.c r <?scarc:1 c,1n he
c c1r r1.ed out; i. e ., 1.,;1tere tr.e re 1.s a c r1t 1.cal c:::ss of b::i.:..c resc,,rc-h
[ .':,!~1
s cientists und prope r labo rator ies. It would not oatcr i~lly incrcnse
~'(,oP'
the b e nefits to th.? 1>ublic to dis trib~tc L.:is ic rcse .:irch cent.::rs cc;ually
across the naLion; such .J distribution o i &ht e v e n he inhi!>itory t o
progress . O.i the ot her h.,n<l , the public do.es !:ave an interest in the
gcoe ra?~ic .::.vail.1.hili ty of inst it:utio:i. s c.:?rrying ou t c linical r<.:sc.i.rch
~ierc t he n~wes t adv.Jnccs in cl i nical oncology a r e av.J il able . The
gco&raphic c:ndatc that Con~ res~ pl aced cpon cance r ce nt e rs is interi
pret ed by ~CI staff to apply only to clinical cnnc~ r c enters. The
lant,u:ige o f t he tbtion.11 Cancer Act of 197 1 r efer:. to " m~w center s [o r
\
clinica l r cs e~ rcl1, trainint~ ~nd dc~oo s tr dtion o f arlv~nccd rli:iRnustic
·c rc•at uc:nt m<? ::Jmds ." On,· 1.1u!'L coucl,il! , l h -: rc f o rc , th:.it ~cu,:i·.,i>:1ic
di~: triuutiou shoul\l he :1 c ons icl !: r ;1 tion unly jn t he a~1arc.l o( CC!;t;s fo:cli nicn l can:::, ·r c<:ntcrs :111rl 110L fo r ,wn- cl ini c:i l c,1ncc:r c c utcrs.
Gco3r., p:1ic <l i .; tribution of co-::1prd1,rns ivc c a nc ..?r center s is i m1,ort.;nt
I
only insofar . ts t hey fulfill Lh.:: clinica l research funct i on .
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3 .4. J

--------

--11,.,L .1 pri r.i.uy r,o:il of the IIC] Cancer C<:nt(•r:; l'rogran,
be to ensure t hat Lhc r c .1rr c,1,1cc r centers of exccllcace for resc.1 cch in
clinic.11 oncolo~y for c:ir.c.::- p.1t i c11Ls :rnd p!1ysici.1r.r. ·,1itltin the U.S.
',1,h.it 1;cr co~prd,.::ndvc ;-ml c l inic:-: l c,H\C'\.·r c:..:n:. ... r-: co:,trihute: to 111ce:Li11i
this uc ...cl. Both ty1w .. of c:1,1·,•r ccntcn: r.hould la• included in
"npprc,pri.Jt..: ceoerar,hi.c diHriLution. "

-Tt,:it t:c1 1 t hrou&h the C.:1 nc r Ccnt.l'rs r,·or,ra;:i, conplcte
it s survey o( the c{foctiv.::,11:s~ of c>.:istin~ c.:nccr c,•nlers • 1·cgion.il
influence.
- n,at, nt the present t i r.11? 1 cancer cent e r s not he
considered (oc.ll poiral s for At.L c.:1nc..:r .lctiviti'-•:; in t h..:ir 11 r1.:iiClns. 11
- 1'h.:it no L1.:>n· co,r'rchcnsivt! cJnccr c...:nt,..rs hi.!
r ccoeni~ed unl.?sn th!:y cur, ..::,tly la.i•.1c the ,cs,,uc"~ rc<jui-:itc for r1.:co~nition ns c o::apreh..:ns i\•e .is dc-t..:r.:iincJ by the ::CA!I.

3.5

\:h nt should l>c thr- R:,lc 0£ :h<! ::c;y C:i: Cl'r C~n t crs Prnr;r.in
:-;,,l \:11.1l .,r<' th<· O. : ..•n:- •. inn,, ~r ___:::_::r,. ui.:-!1in \mi.., 1 it

------.-----·----------- -- ---

TI:e present or~~~iz3tional stru~turc of Lhc Cancer Cc aL·rs
Pr<'t:r.:!1 is \:ithill t he Division o £ C:1nc.!r l,..:sc.1rch Rc:;oi:1·cl'.'s :11:J Cv~lcrs
unJcr t h1• A!.soci.it..: Dir~ct.:>r for th<! Center-. :rnJ ·r: ..•.1L.l•.:nt Pro~:ra., .
'jnc Office e;f the A:;:.oci.::tc llircctor for th.: Ccnl<:r:: ,'lnd Tt c,1Lr.i, u l l'roz r nct incluJc:; :
(l) the Cc.1t,.r:. 1\:-:in-.h - ,1doini.!::. r.1Lion :1nJ :.~.m::;c1.i.?11L
o f CCSG :mJ cx;>lor.J 1• .>ry ir.cnts; (2) t he i~..:sc.,rch ;".1ci li ti..:!: f;r:rnd a adninisLr.ition and uan.1~~!.:1 ''nt of co11:: truction i~r.::11ts; m,d (3) th~
Di.a~~nosi:. .ind Trc,1Lc.-:n t nr.,:.ch - .:d.:iinistru:ion :inc na,,.,~\! =1c·nt: cf
clinic.11 proerac project: r.r.ints and cc r l ain clii.ic,il rcsc.'.\rch tr.111:..s.

An cv:1luation effor t durin~ 1975-76 conductrd by the C~ntcrs
~n<l Trcnlr,•.!n t: l'ro~r.-::..1, DCR,'C 1 r ;:iist:tl .:t n u•-~c:- of i !-su.::-; rcp..irdin-~ th•
ir1tcr1131 .1J"":1i11istr.:::ion ~nd or,::rni.:::t:.i.oaJl p~:ic,·,,t·•:~t o[ th..: i'tot r.1.:1 .
Duri u:; thc cv.1 luntion rrncc· .. 'l , 3 S :~er ::enior !.t::ff ·.·~rt· intcrvir.:.:d
as l o th..:ir vit.:--'·· rc;:.1 1·.!i.1.~ the Ccntl.!r!. .:n<l T:-c•.,t~.,.•c :: l'rc,,:ra.::. ~tn(f
1.~c1.,! ,cr~1 int..:rvi.c\:,·,1 inc-1.11<!,·cl Llic llCI Din::ctor, lht• A~ f.oc i..1~c Uirc•ctt,r;
in Lhc o:>/;:c1 :md :..clecL1....! lkpu:.y Diri:-r::o:-!: , ,\r,~-,ci:iL, Direct,:-:., ,"111..I
Ur;:i:,.-h Cl,:..:fr.. Tlt,· s..:.1 jo ~i.:y Cl( Lhc ro•.,.::•_'nts 11.:tdc cluri11~ t h,·.•: i 1.t,•rv icw;; (•,1. :n o[ ll~) fall i11lo t h..: cn:,,•~,,::y c,f "::c1 ,· l.1ini!.tr,,Li ·,/
tt:tn~,z,•r...:nt." Of this 51.11. , :t l :tr~.:: :,:tjurily Cl~ Lil,· C<' ..:1.:11::s l u:ust:J
on Lh-:? "i11:: crw1 l .:icbinir. t1·.1tioa ,ind oq;.iai.;!:tli.,:,."
zat ionn l

1 h..:sc cor,,...cnts i-um~cst r>d the follo1,1i11r. five ro:.!:iblc
0 1 ,L ions:

01 • .Jn i-

1
I

I

I

•

•

.e

•
16
1.
cou ld r emain m,chn11~;\!<l.

2.

The C:mc,!r Ccntc.rs l'rn~r.,n l C\Cilt i o,1 could rc1,1.,i

\.•l,crc

· i t i s aud Lhc Diai:;1t1., i:; ::aJ Tr..:.::tmc.it llrnncl1 be movcJ .
3. ~~ C~nc~r Ccntcls Progr;1m co~ld be MOV~d to another
Divi sio1t ( DC'f/ DCCR).

4. A se?a~ate resou~cc Division could be created includin~
the Cancer Centers Progra~ .
5. The Cancer Centers l'ro~rac could b e i;iovcd to the O[fice
of the Director.

-That the C.mccr Centers l'ro1;raa n.·:ma~cr.lent rc·.,in
in t he nivi sion of C.::nccr Rr•:earch !tcsourccs ,ind Cf'ntcr:; ,:rnd be hc .. ,h~,l
b) an Ac~ociatc DiL~ctor h,~in~ th~ authority to or~auize anJ :;taf!
th~ PrograQ lo c arry out his r esponsibilities.
·- -,·h:,L the ,\s~oc iatc Dir~ctor f or th e> C:mccr Cc=: tcrs
rror.r:im he rcsponr.ihlc for n:ln,,~.::..c:i t :mJ .id-r.inistratio:i of Clnly C~!.iG,
:in.;! the u-$" o{ C}~:'lor:it .. ry ~:-an::r. .is thi:-:,• rcl,.L\: to the tcv\_• l or ::!:lt of
c-.occr c ent ..·r:-: . 1,H~ 1.1.,na:1.• ·ir·nt anJ ad:11i 11 :scr.1L i.on o { Lhc> .Ui:i~n.,•· i •: ..•,J
1·re:it111ent Rr:inc:1 an.I l!:,· i .... ::c :i1·ch r.1ci 1 iL i,·!: lk.1nd1 ::ho\tld not be :::,c
responsib ility uf tl1c A:;!.o::i.;te i>ircctor (or lh..: <:anccr Ccn:.c:-~ :•rv~.t·,,:i.
1

--Th:it tlte ::er C:inccr Centers J>roc r:11:i 1:1.:tn:i,~<·:.1c11:. b.: :i
sourc..: of infurr:atioa :i:i I prohr.1:1 t,u i t!.:ince, therefor e ::..::vinr, :i tri:i_;cf un::tion to ni,sist c.:nc ... r c,·utcrs uith contacts an.I in(or::i:iLion fr:c..,
NCI conccrnins oL'!ltcr .1:;1 .:C L!, an:i activities of Lhc 1:aLio.::. l C.rncer
Pro&r:\1:i.
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April 26, 1977

C. Gordon Zubrod, M.D.
Director
CompreheD&ive Cancer Center
P.

o.

fort.be State of Florida

Box 520875, Biaoayne Annex

UDJ.v~raity of Miami
M:lamS, norida 33134

Dear Gordon :
Tballk you for your letter of March 25. With Doctor Geha.n's
expertise and valuable izaput I would prefer tbat be remaill
011 the COPID1ttee.
I 1'0Uld also like for Or. Albert O Ullll to
attend the next meeting with the Food and Drug Administration aa a lecal adviaor and ilCl liaison member. Without
Doctor Gwul'a asaiatuce we 1'0uld not have made the progress
to date witll the fl>l. Our ioatitution will pay for any
travel expeuee incurred by Doctor Gunn for this meeting.
S1.Jlcerely yours,

R. Lee Cl.t.rk, M.D .
President
aLC: jb

Dictated by RLC and signed in his absence
bee:

Cr . Gunn

:..
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.

-

UNIVERSITY OF MIAMI
MIANI, FLORIDA S'SIS4

......

1-doa:
CBNTRB HOUSE
ROOF GARDIN - PENT HOUSE
(305) 547-6096

~
:
DSPARTIIIDff OP 01100LOGY
SCHOOL 0 , IIEDICINB
P. 0. BOX 520875, BISCAYNE ANNEX

March 25, 1977

R. Lee Clark, M.D.
President
The University of Texas
System Cancer Canter
Texas Medical Center
Houston, Texas 77030
Dear Lee:
It was so nice to meet with you in Atlanta and I
thought the meeting of the Board of Directors was informative
and productive.
We did speak about Albert Gunn and the possibility of
his attending our next meeting with the Food and Drug Administration. I will be happy to consider this.and I think we
have two options: One would be that he would be invited as
a consultant to a meeting when we are meeting the Food and
Drug Administration. I have looked into this after seeing
you in Atlanta and I find the procedure under the new contract
rather cumbersome and might not be accomplished in time to
invite him to the meeting. I therefore would be glad to
invite him if you could pay his expenses . The other option
would be that he might replace Ed Gehan on the committee and
become a permanent member. If you want
to nominate him i n
place of Ed Gehan as representative of M. D. Anderson on the
comnittee, please let me know and I will make this recommendation to Bill Shingleton. I hope Dr. Gunn will be able
to come in one way or another.
With warm regards.
Sincerely yours,

c.

Gordon Zubrod, M.D.
Director
Comprehensive Cancer Center
for the State of Florida
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April 19, 1 977

Dr. Robert Hickey
Chairman, Task 3, 4, aod 5 Patient Int'ormation System
Asaociatioa or American Cancer
Institutes
M.D. Anderson Eos pital and Tumor
Institute
Houstoo, Texas 77030
Dear Bob:
I am writing you concerning the r ecent letter that I
rece ived from Dr. J ohn Laszlo, Professor of Medicine at Duke Univers ity
Medical School which i s a follow-up of his discussion on 'fltY r eport to
the AACI concerning the activities of the Commission oo Cancer of the
Aoerican College of Surgeons.
Knowing the temper of the climate of tile Ame.r ice.o College
of Surgeons conce rning "Cance r Programs" and the Cancer Registry Manual
·o1hicb tbe CoDlll1 ssion on Cance.r has prepared for distribution t o some 750
approved cancer programs, I ~aa pleased to have the opportunity to again
chat with you concerning Dr . Laszlo 's proposal. I am glad t hat you fee l
the proposal should be remanded back to the Board of Directors of the
AACI for further evaluation at the June 26- 28, 1977, meeting at which time
I could be given more explicit instructions as the liaison representative
from the AACI re submitting this or any other report to the Ca:mission on
Cancer of the American College of Surgeons.
I feel certain that Drs. Shingleton and o-.ens would
certainly go along with this approach . We will be deali.ng with a more or
less monolithic stance on the part o~ 11r . Andrew Mayer, Assistant Director
of the ACS and tbe Commiss ion on Cancer Will have to consider carefully
the reasons why any changes should be made in the College of Surgeons
Cancer Registry Manual.
I am sending a copy of this cote to Drs . Sningleton ,
Owens, and Mi.rand askiDfl that this matter be put on the agenda of the
Board of Directors meet:'& in June.

f,f D ANDC.,:,<IN HOSrfTAL AND TUMOlt L'IIS Tl'TUTT:

£XTltAMURAI PltOCAAMS DIVISION
UNIVUSln CANCLlt FOUNDATION

0,,611,. J

A•w• ..,, Rtll•hlll•/w1t (,,.;,,

c..,-,,1.,-.._, l1111n111111u

T M ~ Meyf-

Colulio,• 11,, Stusn

z._..
J.ckcy
"' 2
Apr.:.l -9,

19Tr

: t :-cs.-. ~ !._ r.a,..-t: -: ••c ~:-h..'lit:; to
-S."t.,er 11.!:t!l t.e Board at thr..t 't!::e .

/ti
,-!l!C,. . , • J .

-iSCl:SS

v~,;·, , ,

c:: :
ycrs.!~·
r.: -.;o

.,... ..,...... . .

-C.--ege
11.:l.rr:..~

ll

sc:::e

r

:o ago..:i
r::, _ :"'ee.:.
:he
·---Ch t;ic,e

Jent at.•te
sion c~

::!~-C~,:,r
e:'u......y
CO!'l!:

..... .a '

JT . :i!.l~a.: ~::-o-e• C:l
: :-. }-~~.r: •t?!?S
n- R. lee C-!.U'k
.. Ed ~ ~a:-:::

!:b~

}·

r:

I
I

\

coo• an ..
TCI.C.~ MO-.t .,._.._..q.1,

~T•L.

J.nu r\· 1-, 1n,~

,.._..,._,:91

Or . • 'urr 'II M. Copcl{l·1d
''.D. \nderson Tuoor In Lit tc
rni-.,. of Texas Syste- C nee: C~ntcr
Houst: n. Texas

Dear Dr. Copeland:
the

Thi i!- in follo1o.·-i:p o: our di c.u~sion of vour re;,ort to
A s so c i a : i o n o :
n r i c an Ca n c e :- l n s t i t u t e .. 1n yo u r cap a c i t "-

1 i a is on ~p-~ r :
the C ~!ssivn or. Cnnccr of :he \-erican
Colle c ~: ~ur ons. You now ~c hav, ~orkcc verv hard under
th~ cir~ction of Or. Rob rt h.cke, ::c ~ooe up ~ith a
n:i,factorv oini~al data foroat for all pa:ien:s ~i:h cancer ·h
co-e to our cancer center~ an~ :bi, ha been nccep:ed by the
AACI for all ~f ~cs cooprehen~ive center~ anc speci.,.ized
centers. The Association of Co--uni:v Cancer Centers 1s a -o
intere,tet ir. u,in£ our 'or~nt - in prclicinary expolorat:on
ith ~ .
Dr. R. ice Clnr~ nd Dr. Hicke· hnvc ·u~t ~pok n to
~ur AACl - -b~r ~ip dnd ta:•cd in t~r-, of intern tional ~oprut.on en clin;cul catn. •ne c1e- n: o(' ~hich
i h: ~ell be
our -in!-al data ,;v. tc
end th.it -.:o.i
I -oulc ·1~c :o rccO
u
on Can-er of th A~\ricJn Col

the Cox::.::d :sion
ns our propo~al to
the f r-s : h :
c --it:ec a: the reqcP.St
~

for~~ that ...-e ha~
urrcnt.y in us .
o: Dr. Ha~e r and -ad~
v •cclio~~
fJ
no~n in ccc:1n
:ha:
~ere held n couple f ~ear
undersranc the
cci ion
ho...-ev~r • ...-a, not to adop: ur for~ und a: :.e sa e ti-c this
force~ u
to crv
dRta ...-hich both for s require.
I kn~
:hat Dr. Maver:
, that tr.c di:'€renccs arc tr.vial bu: thcv
llre icp r: ~t :o
c
.\'c been
1: t de:1~h:
~i~h
vears
: \lode. ...-ith the ne1o.• ,v t .. .:: .ind ...-e ,-:-c.hel
th .. rs i : nn one rcquc ts.
Id
think
the 'a t th.it : .c anccr enters arc en:husin~:i
n ~ 5~ tc- as oppo ed to
t the· have bctn din~ i n .
anc :hev w~ll be vcrY vnl
le re~ urc
Coo~is i
Cancer in providin ~u.d n e a
d
al
01:t the tr.i ::..,d State
n
i
n the ... for nncc o: tumor rc1;1.str1 s bv :: c C
i n
c"'r i
v ili..abl c but I thin :.he lcnd.,rship role ot i;anccr
:i v.:r:,. posi.ti\'t;: factor in Ll.~ v~.rs to co.::e.
u,c
arc

~

~=

1 ac taking :he lfbtTt~ of :se~din~ a copv of this 1 tt r :.o
r AACl ,ask orcc
Robert H1ckev since h~ is the Chair-an of
..
ith
kindc,.t r g .. re,
he cny hav~ ~~me sug~cstions of his o...-n .
Sincercl"-,

er: Dr. Rohert Hick~v

JohJ~ l o , ~LD.
Pr~f('SSOr of }lpdirlne
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Today'~ Date
0

dd-mmm-yy

I

..,

-

. ,.

•

i

I •

.cce11ion No.

I

Hi1tory No.

Patient'• Name

Sex

last

fir1t

Street Address

mlddle

maiden

Birthplace

Telephone

city/ county

City

State

Zip
State /Country

Lifetime Occupation
Birth date

dd-mmm-yy

County
Soc . Sec. No.

Race

Contact Name

Relationshi p

Marital Status

Contact Address

Spouse's firat name

Telephone
Zip

Primary Physician
or C linlc Name

Primary Physician
or Clinic Address

Telephone

Zip

Duke Service / Clinic with
Pr i mary Responsi bilit y

Duke Physi cian(s)

Pr ior Hi story of Cancer (Verbatim)

Dote o f 1st recognition
of disease by pat ient
or screeni ng

Dote of 1st phys icion
contact

Bas,s for def. d1og.
Bi opsy
Cyt ology
Other

mmm-yy
Inst , tu tion at which
def. diog . mode

Dote o f def i n1t1ve
d1oonosi! of cancer

mmm-yy

mmm-yy

Address

Duke Confirmat ion
Conf i rmed
Not confirmed
Unavail able

street
city
Pr ior treatment of this cancer:
Surgery
Im munotherapy
Chemotherapy
Endocrine
Radiation
Non•
Radioisotopes

Anatomic Site

I CO - 0

Histologic Type

ICO - 0

t..AN<.1-. H. f l.OW !.111::t. I'

.
I ni tia l
Wo r kuo

Access i on No :

Nal'le:
Hx. ~o:

DD

DATE

mmm

yyyy
NO CHANCE
STATUS
EXTENT
New Site of

Me t astasis
Evidence fo r
Met astasis

'

Pe rfo r man ce
S t .i t us

:r

%

:t

%

%

%

TREATMEKT
PROTOCOL
y :
N.

11

ye s l
no

2

3
I

4

I

5
6

7

8

HOSPIT ALIZED:
,\ : Ad::iission
D : Discharge
S : Service
PHYSICAL EXA~:
y : Yes
N : No

I

I
dr

AUTOPSY

PLACE OF DEATH

DATE OF DE ATH
lllllllll

yy

city

stat e

coun t y

ye s __

no

--

•

now
NO CHANCE :

!>IIEET IH t' I Nl Tl ON

In lh n x If, nn rou~l11r follow-up, no-pec t
pntient'11 condition ls ch nnged,

or the

STATUS:

REH :
PER:
REC:
D/C:
D/0:
D/U:
UN:
NEW:

Alive, no evidence of residual c ance r (remission)
Alivl' , with evidence of persistent cancer
Alive , with evidence of recurrence (after re missi on)
Dead, of cancer
Dead, o ther cau s e s
Dead , unknown cau ses
Unknow n (lost to F/U)
Alive , untreated cancer

EXTENT:

I/S : In si t u
LOC: Localized
INV: Invasive primary disea se
LXM: Spread to regional lymph nodes
KET: ~etastatic
DIF: Diffuse disease
UN :
Unknown
(S tage): S taging , &?p r opriate to specific malignancy

!'fETASTASIS:
RLN: Regional lymph nodes
LU:
Lung parenchyma
CNS : Brain
BM: !lone mar r ov
PL:
Pleur a

Ll :

PER:
BO:
SK:
OT:

Liver
Peritone um
Bone
Skin
Other (Describe)

EVIDENCE : OR XETASTASIS:
BI:
Biopsy
SC:
Scan of appropriate or~an
XR:
X-ray of appropria te organ
AR:
Arteriographv
CYT: Cytology from ap p roFriate site
LAB: Lab data (hematologic, enzymes , immunologic tests, etc. , )
PE:
Physical exac
FERFOL~A.~CE STATUS:

100%
90%
80%
70 %

60%
50%
40%
30%
20%
10%

Normal, no complaints ; no evidence of disease
Able to carry on normal activity; no major signs or
symptoms of disease.
Normal acti vity with effort; some signs and symptoms of disease
Cares for self ; unable to carry on normal activity or do
acti v e worlt.
Requires occasional assistance, but is able to care for most
of his need , .
Requires considerable assistance and frequent medical care,
Disabled; requires special care and assi s tance.
Severely disabled; hospitalization is indicated, although
death not imminent.
Very si~k;hospitalizatlon necessary; active supportive
treatcent ls necessary.
~oribund, fatal processes progres i ing rap idly .

PERFORMANCE STAT US ( enter after% ) :
C

1f deteriorati o n of s tatus is due

0

lf deterioration of status is n o t

t o can c er
due to c an cer

PROTOCOL:

Y
N

Tf patient is on a protocol
If patient is no t on a protocol

KOSPlTALIZED:

A: Admissi on Dat e
B:
Discharge Date
S:
Service
TllE ATKENT PROTOCOL DESCRIPTI ON:
S:

Su r gical

C:

Che ■otherapy

ll:
Radiation
. , . ~.~inf•nr"~~-

PHYSICAL EXAM SISCE LAST FOLLOW-UP:
Y:

N:

Yes
No

IT: Immunotherapy
E:
End oc rine
OT: Other

·•

~ THE ,□X CHASE e
DI CANCER CENTER
7701 BUAHOLMa Av.M.la • ~ PENNSYL VANIA 1am • 21Sf.!l•a-1000

TIMOTHY R . TALBOT. JR. M.0.
PR■-Ol!NT

A-pril 11, 1977
Dr. Willf.llll Shingleton
Directo1
Duke University Comprehensive
Cancer Center
Duke University Medical Center
Durham, North carolina 27710
Dear Bill:
I apologize for taking , long to write you. The last ten days seem
t o have been all-absorbing. In the mea ntime, I have rec.e ived Denny Hammond's
let::~ -:- to you dated 31 Mar ch. I agree with all that he said. I also agree
with ;.." Owen's letter of 23 March.
As I recall oi;r understanding, you will write Benno, in your capacity
as President ~f AACI, t ong the fol lowing lines or concepts:
l
' .e wish to give endorsement and encouragement to some of
the principal recocm:oendations of the NCI staff committee Teport as printed in
the Cancer Letter - 25 February 1977, pages 4, 5, and 6. Specifically , we
believe that the NCI needs to define a Cancer Centers Program including "a
program plan which will guide the program to its inte~ded objectives."
2. There needs to be an adequate staff in NCI, preferably
within the Division of Cancer Research Resources and Centers, which is not
true now, especially when one compares i t to other divisions of NCI .
3. It is apparent that existing financial commitments by the
Congress to NCI as a whole will not be adequate to ensure that all meritorious
programs can be funded. Therefore, the need to establish priorities assumes
greater importance tha n ever ; and, as a corollary , the need to establish a
sound and rational method for determining budgets for s peci fic programs is c:
great importance. Many of us have reason to believe that s omething is awry
when, in the face of an increase from $180,000,000 in 1970 to $815,000 ,000 in
1977, approved Core grants may actually be reduced in some cases and will
certainly be seriously restricted in most cases. Therefore, we are convi nced
that unless a Cancer Centers Program is defined as noted above, and unless
the budgeting process within NCI gives at least equal weight to the Centers,
then the entire centers Program is doomed to failure.

THa M..-.::AN D"C:01. ocac HOaPITAL e TMI! INtlTffUTI! F0A CANCER REaeARCH

'
or. William Shingleton

April 11, 1977

-2-

We are also concerned about the influence of "in house" pro~ams versus centers
and investigator initiated programs , on the budgetary priorities.
4. I agree with Al Owens that we are now faced with .. "Catch 22"
Core is the major instrument for development and stability of centers but only
if Core itself is stable £rem the NCI budgeting point of view.

5. I agree that excellence as determined by peer review should
be the basis upon which individual protects are funded; but, once that process
is accepted, then, I fail to see how Core can be reduced without serious consequences.
6. Are there sixty three centers? As noted by Denny, I thi.nk
that this is really an absurdity! But, I don't know ho., to lick it. (See
last paragraph of page 1 of Denny ' s letter) .

S'~wne
=~
t ~a:=-. ou have received
I hope that this is useful to ~~~=.: .:.r .- a~s-=-=a transcript of our meeting with the
Cancer Pane'l
I r eceived a
copy and have returned it with mi.nor c:oilllll!'ttt'S.-------_.,,
Kind regards.
Sincerely yours,

T. R. Talbot, J r.
TRT:pb
cc:

R. L. Clark •

D. Haamond
A. Owens

f
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I

J
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OOICI
I
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association of amencan cancer institutes

O FFICERS
Pr6arm

Wilh~m W, Shlngleton, M.D,
Oulu LDmorthtnsi, t Ca11ur
umrr
D,.,rhom, \ orrh Carolina

April 4, 1977

17ct PrwcJmt
C. Gordon Zubrod. ~ .D.
0,mpuhtnsi•~ C.,nu:r
Ctllltr for tht St~ 01
F'forlda
~,.,'"'• Florida
~crttan, TrtJ<uff•

Edwin A . Mir.and, Ph.D.,

D.SC.

Ros...~ 1 fvrit

,,,,..,,.,,o,

/"'Sl,tuU

&.••.::.o, , ~.. I ~rll

OT. R. Lee Clark
President
The University of Texas System Cancer Center
M. D. Anderson Hospital and Tumor Institute
6723 Bertner Avenue
Houston, Texas 77030
Dear Lee:

BOARD OF DIR ECTORS

A.1ben H. Ow~.ns. Jr .. M.D.
- ~irman
/JJh .._,,,, I/Jr,

-.1~.,1

011- H. 8 e.hn. M.O.

Rocr.,,u•,

\l, ..

~.-.c,,.,

Thank rou for fonrarding t o me the membership l is t of the
Oncologic Drugs Advisory Cormnittee. I am referring this t o
Gordon :ubrod for his review and recommendation.
With all good wishes, I am

R. Lff Clark • ._, D
lioJSion, r.:,.;,

Sincerely your s,

-)

Ln.is L Cor~II. M.D.
CJfrlat'I, , ...

/tr~.

9:. (

OwleS A. E..ans. \1. 0.
S«lt: 't ll,.:s/1111,;ton

William W. Shingleton,~- D.
President
Association of American
Cancer Institutes

G. !nnrmn Hammond , M.D.
LtH o\n~ln, Ca• 'oM,a
Hfflr) C P i101 , '1.0 ,
\ faa,...nn. .H , li'C/11'\,,..

\

WWS :err
cc: Dr. C. Gordon ~ubrod

March 2 S • 1177

Dr. William W. Shingleton
Dulce Comprehenalve Cancer Center
Dulce Hoapltal
P. 0. Box 3814
i)urbam. North Carolina 2 7710
Dear Doctor SbJnoleton:
Attached 11 a Uat of the current members of the Onoolo0lc Druos
Advlaory Committee. A• you wlll note, the terms of both r'octor
Scheln and 'Coctor SullJvan expire ln June of this year. Slnce
the AACI adopted ~ resolution at our Jsnuary meeting wglno that
tbla Advlaory Committee of the Food and Druo Adm!nlstratlon be
olven additional authority over the development of lnvesUgaUve
new druos and devlce1 , I thoughl that the Association might
want to recommend physicians to fill the aeata belno vacated
by Doctor Scbeln and Doctor Sullivan .
RecommendaUon1 are now belng accepted by Dr . Cyrus Maxwell,
Executive Secretary of the Onoologtc Drugs Advllory Committee .
Bureau of Drugs, Food and Druo Admlnl1trat1on, 5600 Fishers Lane,
Rockville. Maryland. Please let me know lf 1 can be of any assistance.
Sincerely yours .

R• Lee Clark , M . D •
President
RLC/jah
encl

--

Oncologic Drugs Advisory Committee
Chairman:
Shlrnkin , Michael B. , M. D. (l.978)
Professor of Community Medicine
and Oncology
School of Medicine
University of California
San Diego, California 92101
Members:
**Schein, Philip S., M.D. (1977)
Head, Division of Medical Onc ology
Department of Medicine
Georgetown University Hosp ital
Was hington, D.C. 20007

Executive Secretary:
Maxwell, Cyrus, M .D.
Bureau of Drugs
Food a n-J Drug Administration
5600 Fishers Lane
Rockville, Maryland

**Sullivan, Margaret P., M. D. (1977)
Professor of Pediatrics
The UnivEr sity of Texas
M . D. Anderson Hospital & Tumor Inst.
Houston, Texas 77025

Balcerzai< , Stanle y P. , Jr. 1 M . D. (1979)
Professor of Medicine & Director of
the Divisi on of He matology & Oncology
The Ohio State t:niversi'. y
Columbus , Ohio 43210

Moertel, Charles G ., M .D. (1978)
Director of Clinical Cancer Research
Department of Oncology
Mayo Clinic
Rochester, Minnesota 55901

Whitaker , Jo h} :'I.!. D . (1980)
Capitol Medical Clinic
Austin , Texas

McHug h , Richard, M. D , (1980) •
Professor of Biometry
School of Public Health
University of Minnesota
Minneapolis, Minnes ota

**Tenns expire in June, 1977

•
THE mtlERSrJ'Y OF TEXAS SYSTEM acER CENTER
M. D. ANDERSON HOSPITAL .-\~D TUMOR INSTITUTE

Interoffice ~lemorandum
TO

Dr. Clark

FROM

DATE

January 14, 1977

Mel Gallagher

SUBJECT

Oncologic Drugs Advisory Committee

Chairman:
Shimk1n. Michael B. M,D.( 197$
Professor of Community Medicine
and Oncology
School of Medicine
University of California
San Diego, California 92101
Members:
** Schein. Philip S., M.D. (1977)
Head. Division of Medical Oncology
Department of Medicine
Georgetown Universtty Hospital
Washington, D.C. 20007

Executive Secretary:
Maxwell, Cyrus I M. D.

Bureau of Drugs
Food and Drug Administration
5600 Fishers Lane
RockviUe, Maryland

**Sullivan. Margaret P,. M,D. (1977)
Professor of Pediatrics
The University of Texas
M. D. Anderson Hospital and Tumor Institute
Houston, Texas 77025

Balcerzak. Stanley P., Jr, 1 M.D, (19 79)
Professor of Medicine & Director of
the Division of Hematology & Oncol ogy
The Ohio State t:niversity
Colum!'lus, Ohio 43210

Moertel. Charles G,. M,D. (1978)
Director of Clinical Cancer Research
Department of Oncology
Mayo C linic
Rochester, Minnesota 55901

Whitaker . John . M.D.
Capitol Medical C"Hnic
Austin, Texas

Mc Hugh . Richard , M, D. (1980)
Professor of Biometry
School of Public Health
University of Minnesota
Minneapolis, Minnesota

(1980)

-Established on October 24, 1973; expiration date Octobe r 24, 1977 , but will be routinely
renewed by Secretary of HEW' this summer.
-Consists of nine members (including the Chairman) appointed by Commissioner of FDA for
4 year terms. (Currently only eight members)
-Met twice during 1976.
-Stated function - "Reviews and evaluates all available data concerning the safety and
effectiveness of presently marketed and new prescription drug prcxiucts proposed for
marketing for the treatment of cancer and advises the Commissioner of FDA regarding the
current advances, changing conc~pts, and trends in the field of oncology.
• - **Terms expire l n June, 19 77
-Recommendations from interested parties can be sent to the Executive Secretary, Dr. Maxwell.

cc: Dr. lmll Frelreich
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TO: Dr. Clark
FROM: Me1 Gallagher
RE: Draft letter to Dr. Shingleton on the Oncologic Drugs Advisory Committee

Attached is a list of the current members of the Oncologic Drugs
Advisory Committee. As you will note, the terms of both Dr. Schein
and Dr. Sullivan expire in June of this year. Since the AACI adopted

a resolution at our January meeting urging that ti-ts Advisory Committee
of the Food and Drug Administration be given additional authority over
the development of investigative new drugs and devices, I thought that
the Association might want to recommend physicians to fill the seats
being vacated by Dr. Schein and Dr. Sullivan .
Recommendations are now being accepted by Dr. Cyrus Maxwell,
Executive Secretary of the Oncologic Drugs Advisory Committee,
Bureau o f Drugs, Food and Drug Administration, 5600 Fishers Lane,
Rockville, Maryland. Please let me know if I can be of any assistance.
Sincerel y,

R. Lee Clark, M. D .
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February 18, 1977

371 · 2900

II. LU CLARK, M. O.

,.,_..._

Ms. Anlta Johnson, Attorney
Health Research Group
2000 P Street, N.W.
Washlngton, D. C. 20036
Dear Ms. Johnson:
RESEARCH
EDt:CATI0:00.
8F.R , • 1CE

Your letter addressed to me at the Amencan Cancer Society office !n
New York reached me yesterday.
The d1scusslon of the Amerlcan Cancer Society representatlves about the
problem with the Food and Drug Admlnistration and the issuance of
Investlgatlonal New Drugs (INDs) was expressed last October at a press
conference. Since then, articles have been written concerning that
interview after rather extens1ve exploratory investigatlon by some of the
science writers. I am sure you are famillar with the Associated Press
report of January 19, 1977, which appeared ln numerous papers around
the country mcluding the Washington Post on January 20 .

f\ "

0

~leanwhlle, I met w1th the senicr medical member of the FDA under whom
the drug testlng actlvlty is conducted. Following this meeting in \-\'ashlngton,
i). C .
I lnvlted him to attend a meeting of the Assoc1atlon of American
Cancer Institutes held at The Un1versity of Texas M. D. Anderson Hosp1ta l
and Tumor Institute. This group of cancer Institutes, organized i n 1961 by
flve of us who were directors of what are now called comprehensive cancer
centers, ls presently composed of fifty-six members . We shar e many
mutual problems in our efforts to expedite the care of the cancer patient .
We exchange progress 1n cancer research in general, as well as various
methods to solve managerial problems l n running our cancer certers' progr ams .
We are doi ng all that we can to decrease the extremely l ong time it takes to
generate an 1dea and take it to the various fields of re search for ver i f ication
until lt can be applied at the oeds1de. We think lt ls indef ens ible that we are .
generally, unabl e t o carry out such plans in less than fifteen years. We were
very hopeful that with the National Cancer Plan this could be done ln c v n s1derably less time, but thl r has not been the case to date. Therefore, those of
us concerned flnd lt a very sorrowful fact that the more we get involved with
governmental bureauracy , the longer lt takes to accomplish anything.

Ms. Anita Johnson
february 18, 1977
Page two

At the meeting in Houston •ve had a conference between the leaders of
the cancer institutes and tt,,- senior physician from the Food and Drug
Administration, and including his suggestions the Association of American
Cancer Institutes formulated and passed a resolutlon which ls enclosed.
We hope this resolution can be carried out. At the same time, we have
also asked the National Cancer Institute to continue negotlatlons with
the FDA so that a solution may be found which we can all live Wlth in
good conscience •
Also, I am sending you a position statement of the American Cancer
Society on the use of new drugs and new drug comblnatlons ln the treatment of cancer. This statement was formulated after discussion among
members of the American Cancer Society's Medical and Scientific Committee;
Dr. Frank Rauscher, ACS Senior Vice President for Research; Dr. Arthur
Holleb, ACS Senior Vice President for Medical Affairs; and me.
Answers to the other questions raised ln your letter concerning the
particulars of the INDs which were delayed over a year or removed from
investigation by the FDA order have been prarided to you, I see from
your letter of February l, 1977 to Congressman Paul Rogers.

S ancercly yours ,

-,

/'/. /y.✓-<- ..._
,,

I'

R. Lee Clark, M .D.
President
cc: Dr. Arthur I . Holleb
Dr. Frank J. Rauscher

AACI RBSOLU'rION
RESOLVED

Tne Association of' American Car:ce:c Institutes is concerned

about the lag in new anticancer drug cii?veloµ:11 <:nt and clinical
u3age and urges the Federal Drug Adrninis~ration and the

~ational Ca.'1cer Institute to resolve ~his lag problem as soon
as possible. MCI is also concerned about t he process of
formulatio n of policy for new a.~ticance? c~J6 investigation
and stuay of new devices.
In order to facilitate reso:ution of currer.t proble~s a.~d

f)rO!r.Ote a op roprlate policy develof)ment for anticancer drug
:; t .id:·, :. t is r ?co;:-;:nended tha: t:-.e Oncolo 6 ic Drugs Ad·,isory

Invesci.6at i.ona: riew Drugs (::~Js) a:-.,:i rela te~ policy matters.

It ~s re~~ested that the ~as~

:o

Co~~it~ee of t he

AACI

be c:-..a.rged with carrying these rc!cc;:-_-::endations to the FDA a.'1d

continue to serve to bring to t~e attent:~n o~ the FDA matters
of co:1cern to the AACI 'relat ive to ::e~-r ar.t ica."'lcer drug develop-

:r.e:e:: ar.d clinical usage a.."'ld the study o~ :,ew devi ces.

POSITIO:t .EMENT OF THE AMERICAN CANCER .IETY
ON THE USE OF flEW DRUGS AND NEW DRUG
COMBINATIONS IN THE TREATMENT OF CANCER

The An:erican Cancer Society believes that the Food and Drug Administration has, for the ~.ost part, served the publ i c well through its regulations
that demand drug efficacy including minimal or known and acceptable levels
of toxicity.

We believe that strict guidelines in the use of drugs must be

enforced particularly for those diseases that are subacute, usually non-lethal
and certainly for patients that are nonterminal for whom other effective and
nontoxic re.~edies are available.
However the overly strict interpretations of FDA regulations by their

~

staff have gre~tly impeded the development of potentially useful drugs for
cancer pati~nts, especially for those that are or will be terminal because
they are refractory to other forms of treatment.

Until more exploitable

differences are found between nonr~l and cancer cells it must be expected that
scme toxicity will occur from drugs expressly designed to kill cells. We must
rely on the very considerable skills of qualified clinical investigators to
USf!'""_the principles of selective toxicity for the benefit of patients who,

having no othe~ recourse, will die from progressive growth of their cancers.
NCI and FDA staff have had many negotiations in the past year on this problem
~

and these negotiations still continue. Some progress has been made . Within
the pas~ month, the FDA has released all I"D applications held up in 1976.

J ~l Sl ATC.ME:, . OF •
AMERICAN CANCER SOCIETY ON TH-E OF
RUGS A~D tlEW DRUG C0.'1BINATIONS W THE TREATMENT OF CANCER

Page 2

FDA has r£ : ent ly suggested regulating combinations of approved single
ant i-cancer drugs by requiring a new IND with each combination. This subject has been men tioned in t heir Oncologic Drug Advisory Group meetings·and
rejected by t he committee.

NCI does not believe that new INO's for the use

of anti-cancer drugs in combination is required by law. The American Cancer
Society sui)ports thi s position and further, we believe that the cancer patient,
particularly the t ermir.al patient, is best served by the prompt application of
cf new drugs or new combinations by qualified investigators, with infonned
~onsent of the patient and for which there are indicative laboratory data.
The American Cancer Society is not a regulatory agency. The Society and
the Nationa l c.~ncer Institute prefer to have the FDA continue this regulato,:-y
activi t y.

A transfer of t~s ir.;::ortant and ccr.iplex function to the fJCI would

r.a ·:e to be considered and supported

by

the Air.eri can Cancer Society in the un-

1i ~e1y event tnat agreen-ents cannot be reached to prevent delays in the use of
re·.-, drugs or new drug combinations for pote.n tial benefit to the apparent
:er.::inal cancer pat i ent.

RECEIVED
Dr . R. Lee Clark
American Cancer Soci~~Y
100:7

It,

uF i';,t£
EXECUWJE.
VICE PiESIDe"lrT
Orn.:i

219 E • 4 2nd St .

Hew York, N.Y.

fEB 10

Dear Dr. Clark:

A December 3, 1976 letter from the Amerj m Cancer Society
national representative in t,,lashington, Nath:1 Polster , requested
a new amendment to the National Cancer Act tc.. _xempt the National
Cancer Institute from scrutiny under the Fede ral Food, D.cug and
Cosmetic Act. As you know, under the latter Ac t, the Food and
Drug Administration has the obligation to oversee drug experimentat ion for the purpose of protecting human subjects and designing
scientifically-adequate protocols.

Mr. Polster refused to disc .iss the ACS l etter and in fact
up on me, stating that he had no reason to talk with me
sine!_. he had "never received any co-operation from [ my] _of flee~"*

hu.>1g

•p
Is it the position of the ~CS that legislation is desirable
exempting NCI-sponsored drug experiments f rom FDA scrutiny? Is
it ~our: positi.on that legislation is necessary? What circumstances
led.:.to. Mr. Polster's letter? What problems has ACS had that led
to~b::ls recommendation? Who in ACS is familiar with the de t ails
o0~spec1fic . drug experiments involved? What steps does ACS
inte'iia to take to further progress of the recommended statut~?

· According to the ACS letter, "The National Cancer Advi sory
Board , and a large nu::iber o~ biorneoical science ad:ninistrators "
support the need for the change . I have been unable to l ocate
any such rec ommendation, and hope t hat you can dire ct me to it.
Who are the large nur.c-er of biomedical science admir.istrators?
If ACS does n o-; s ·..:.;:~~=-t a ne~-, s"';atu-ce , w,hat is t~e proble:n
and solution see n by A:S?

Thank you very much f or your time. If you prefer that I
telepho ne you, please ~nform me of an appropriate time . I am

•The meaning of this is not clear; perhaps you can shed some l ight
on it.
HEALTH RESEARCH GROUP • ~O()() P STREET, N .W., WASHINGTON. D .C. 20036 • (202) 872-0320

,,

anxious to know the details on the drugs involved.
Yours truly~

,

}(

f

February 16. 1977

John S. Spratt, M. D .
Deputy D inctor, Cancer Center
University of Louisville

Health Sclencea Cents
Louisville, Kentucky 40201
Dear Jack:

It waa n!ce to see '"Ad v111t with you ln Houston during the AACI meeting
1n January. Your poaition at Loulavllle sounds most lnteresUng . I was
happy to learn of your recetvlng the American Cancer Society Profeseorshlp
ln CUnical Oncoloqy and your election to the graduate faculty there at
the cancer center. It seem• you are q u!te satisfied and the move was a
moat profitable one.

I wish you every success

1n

your private practice and your future association

with the University of Louisville.

Sincerely

YO'-lrS,

R. Lee C lark, M . D .
President
RLC:Jh

.

.

-

. -

UNIVERSITY Of LOUISVILLE

.

HEAl.111 SCIENaS cmnER
L0UJSVILU. UN11.aY 40201
WALNUT AND
KISTQN STll££TS

CANCEa CENTER

J3Duary l3, 1977

R. Lee Clark, 1\1. D.
President
Universjty of Texas System C'\Jlcer CenteT
Houstcm, Tens 77025

Dear Lee,
I enjoyed visiting with you in Houston and filling you in on Louisville. As
you know I looked around at several places before I decided to separate from Columbtll.
Some of the schools were a little too far advanced and I
rigid in tf.eil' structure
to accomodate a desirable clinical program in cancer. However, I found the enviTonment
here at the Cniverstty of Louisville most receptive to the development of a strong
cancer progr-am.
Specifically the Cancer Center is authorized all the way through tho Board of
Trustees as a graduate institute within the University. It bas it's own Director who
reports to a three man Board which consists of the Dean of the School of Medicine.
the Dean of the Dental School and the Dean of the Graduate School. This Board ls
primarily fur policy support since. a great deal of authority is vested directly in the
hands of the Dtrector. He bas a steering committee to advise him which COl18ists of
broad faculty representation and a system of associates in Oncology which brings
into the Cancer Center scattered elements of the faculty 'Nho wish to concentrate on
cancer. TbPre are a number of interesting programs here which are quite productive
and a number of others are on the drawing board which will see a c ontinued growth
of the program. Louisville is kind of like New Jersey lD that there's an awful lot of
chem.teal industry here and me of the more active programs ls the one on environmental
carcinogenesis concentrating on the vinyl chloride problem.
From my own standpoint I'm particularly attracted by the graduate institute
status of the Cancer Center since I have always had an actf.•,-e interest in graduate
education and tend to use 1his vehicle to build up a number of programs. I' w already
been elected to the graduate faculty and have been site visited f'or an American Cancer
Society Professorship in Cllnical Oncology. I also have a private pract<~ce outlet which
I never bad in Columbia and am en joying the direct patient care side of ttie Louisville
envi roo.ment.

•

•
R. Lee Clark, M. D.
January 13, 1977
Page Two

The situation in Columbia I fear ts in for a sustained period of deterioration
both at the Medilidl School under Wbit.e and at the Cancer Hospital under the present
he.ad of the Division of Heal.th. However, the whole situation might e~ up being
salvaged because a Legislative Committee has taken a very active interest in reviewing
the cancer program. Through thil:l Committee I have the ear of major legislative
committee leadership and hopefully they may make some long-term Improvements
that will be highly beneficial. I have specifically provided them with legislation from
the State of New York and a long consultati\."e report from Robert Goeble on the accomodatlons of the state Civil Service System in New York for cancer clinicians and cancer
scientists at a competitive salary scale. A chance of an umbrella corporation such
as Yarbro has tried to sell them existing or surviving in Missouri ts still nil.
I also happen to believe that these umtrella corporations are detrimental to state
supported programs. You may have a different opinion rut I can provide you with
quite a number of case studies which documents the damage that these corporations
did do.

I'll be glad to visit with you further anytime on the situation. With best wishes.

Sincerely,

~ S . Spratt, Jr., M.D.
Deputy Director, Cancer Center
JSS: bak
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RDS\NELL P49RK MEMDRl4L INSTITUTE
Da,artment of Htaltll • State of New Yort

666 Elm StrHt • Buffalo, New York 14203
Gerald P. Murphy, M.D., Director

Hollis S. Ingraham, M.D., Commissioner

February 15, 1977

Dr. R. Lee Clark, President
University o f Texas System Cancer Center
M. D. Ancierson Hospital and Tumor Institute
Texas Medical Center
Houston, Texas 77030
Dear Dr. Clark:

I wish to acknowledge r eceipt of your check in t he
amount of $500.00 as payment of Annual Dues fo r 1977 for
membership in the Association of American Cancer Institut es.
I appreciate your pr ompt at tention t o t his matte r .
Si ncerely yours,

E. A. Mi r and
Associat e Institut e Director
and ~rof essor , R.P .M.!. ;
Secre t ary- Treasur er, A.A.C .I .
EAM: co

Roswell Par• i.s now on a direct inward dialiq telephone syste11. The nu11ber of this office is._ _ _ _ __

February 10, 1977

D octor Edwin • tv:trand , Secretary-Treasurer
Aa ■ociaUon of American Cancer Institute
Roswell Park Memorial Institute
666 Elm Street
Buffalo, New YClrk 14218
Dear Doctor M lra nd:
Dode.- Clark asked that we send you the minutes of a meeting held a t

~. emortal Sloan-Ketteri119, December 7, on the Cancer Patient Oat-a Sharlng
JX'C)Ject. This meeting lncluded representatives of the fi ve (5) .\ACl member

institutlons participating in the data sharing project witlrC ICA. Another
meetlnQ on the Cancer Patient Data System w a s held Monday, January 1 O,
1n Hou ■ton, and a copy of the minutes of that meeting are attached .
Also, we are eendln9 you a copy of the report o n the regional meeting to
discuss plannln9 of Centralized Patient !:' ta Exchange System lnternatlona Uy
which was held at Ville Ju.if, on December 17.
I hope th!• lnfonnauon will be

u■aul

to you.
Sincerely yours,

(Mrs .) JoAnne Hale
Administrative Assistant t o
R. Lee C la rk , M . D

JAH/m
encls

February 8, 1977

Dr. Wm. W . Shlngletal, Prealdent
A s ■oclaUon of A.mmcan Canaer lnaUtute■

Duk• ComprebeUlft Cancer Center
Dmham, Ncrth Carollna

Dear Bill:

Thank you fCII' your lDYltaUon to aen,e aa AACI Ua1a011 member to
the CICA committee and to ••rve on the AACI nomlnaUng committee
for l 9n. I ahall be pl••ed to aerve ln tbe■e area ■ and have fCll'warded the neceaeary paper■ to Dr. E. A. Mtrand.
I was happy to learn that you bave been appolnted to the National
Cancer Advuory Board. You w1l1 be of great a ■ alatance to this
Board.

Sincerely yours,

R. Lee Clark, M . D .

Pruldent
RLC/m

.

association of amencan cancer institutes
OFFICERS
PRESIOE"IT ALBERT H OWE:-tS. JR., \1.0 ,
John Horii.ms l.,n1\rn,n O,,,o.o.,, Cu,:, fl •

.

-

•·

,,.,., '.DC

VICE PRESIDENT WILLIA., w. SHl!\IG t.( ro, . \1.0 .

Dultt CompnhtnJl•r O,,,ur Ctnttr Di.,.,.:- \

" , .,,,

SECRETARY- TREASURER E.A. \11RA, o, P'>,0 ,
Roswt/1 Part, ,1,/tmor/Q/ /nJ1,t11u, Buf•.i o

\, • • ,,,..,

January 19. 1977

Dr . R. Lee Clark, President

University of Texas System Cancer Center

H. D. Anderson Hospital and Tumor Institute
Texas Medical Center
Rous ton• Texas

77030

Dear Dr. Clark:

I should like to have you serve as the Liaison Representative
to the UICC/CICA for the MCI for the year 1977.
Please complete the attached form and return it to the
Secretary-Treasurer at your earliest convenient.
I hope you will be able :o serve in this capacitv and look
forward to •'Orking with you in the coming year .
Sincerely yours ,

/v,~ k -}-kc. ,-f-i.. b.
Wm. W. Shingleton, H.
President

o.

WWS/o
Attachment

80ARD OF DIRECTORS
R. L« C!Mk \1 .0•• O,i lrnw,
Hou11on, Tr•o,

Ho11J1on Tuos

Ect,,,ard J. Bu11,c, 1,., ~.o.
...,._ Yori!., ""'" y,.,,1,

O,,,drt, Nn,,, Jrr,,y

'4ur•, .,. \1. CoPCl.tnd, M .O
lr•ls L. Coriell, M.0.

G Dcrim~n Hu,,,,.<>nd, \I 0
Los Anqrln CJ' tr,,,, ,1
Htnn C. P,101, \1,0 .
Mod,son, II ,scons "

"1

Please check one:
1 do _X..a...-• I do not

ac1.:ept the appointment to serve as Liai son

Representative to the UlCC/CICA f o r the A. A. C. 1 . for the year 1977 .

Signatur e
Date ~nuary 25, 1977

Return ::o :
Or . E. A. "'.-and , Secr~tary- : reasure r, AACI

Roswell Park ~ or ial Institute
666 Ell?l Str eet
Buffalo , ~ew York 14263

Odcl

association of amencan cancer institutes
OFFICERS
PRESIDENT >\LBERT H. OWE'IS IR \1 0
C,,,,. 8-t - rr

/ot,n Hor,4,nJ (. .,,.trJ.tt• 0-,,010-1t

11..,.-, b,1,1

VICE PRESIDENT WILLll\\1 '1\ , SltllllGLETOIII, \I.O.
DJ~• Compr,,w-r,i,, t C411ur

c,,,,,, o,.,...,_ \ ,.. Q/-r,I,,.,

SECRETARY TRl:ASURER l.A, \\IRA,o , Pll,O.
Ros-~// Port, 'frmorM /n1ti1uu &,/Iv o. \, ~ I r,,t

January 19, 1977

Dr. R. Lee Clark, President
Un' ✓ersity

of Texas Sys tem Cancer Center

M. D. Ande r son Hospital and Tumor Institute
Texas Medical Center
Houston, Texas 77030
Dear Dr. Clar k :

I should like to have you serve in your capacity as a
Past President of the AACl , as a me:nber of the Nominating COllllll:ittee
for the year 1977.
Pl ease complete the attached £om and return it t o the
Secretary-Treasurer at your earliest convenience .

I ttust you will be able to accept this appointment and
l look forward to the opportunity of working with you in the
coming year .
Sincerely you r s ,
)

""""'1

~

I

I'

,--.

J..-c. ..,S..."- '-i<-L..("''

Wm . W. Shingleton , M. D.
Pres ident
WS /o
Attac hment

BOARD Of DIRECTORS
R. Lcc Ou._, 114.0 .• O,um~n
Houston, To•s

\turnv '14. Co~lffld, \1.0 .
Houston Tu11s

G. ~nman H;am..- I'd, \1 0 ,

Echirud J. lq1tk, It., ~ -D.
'lltw Yor,t. IV,.., Yor•

t.n.i, L. Coritll, M.O.
Ctlndrn,

Henn C. l',101, '14.0
M«/uo,,, lt'6COIIJ, ,1

/1,n,,, ,,,_,,

Ch,rle, A. E,,ans, M.O.
SHnlr, .,_,,,_,,,on

Lo$ An9t/t<, Coltlc,m ,1

,

Please check one :
I do

_ x_·--~

1 do not _ _ _ accept the appointme nt to serve as a member

of the Nomina t ing Committee for the A.A.C.I . for the year 1977.

,

. . 4 _,.·, (:/4cc.· 1.t:.
Signature
Date

1anyary 25 , 1977

Return to:

Dr. E. A. ~rand, Secr etary-Treasu r er , MCI
Roswell Park }tecoria l Institute
666 Elm Street
Buffalo , New York 14263
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January 28, 1977

Dr. Jan Stelner

o..

DlractGI'
19nate
llUnota Cucer C OWIC11

37 South Waba ■b AveAue
Chlc:11190. UUnota 60603
D eer Doctor Stainer:

It ••• 1e1111l a PIN._. to &N you at tbe IDffU.n; of the AaaoclaUon
ol Amenclln Caaaar lutltute■ 1n Houston. I am dellqhted that you
haft jolnad tbe tam 1D Ch101190. You hlift
a ftlY d1ff1cult
fob. howu.-. 1f Mfc»De CIIII Diab the progsaw go, I am ■ure YoU Cllll.
I haft alway• •atoted your Npcloua CmtJNJlb and vtew■ 011 tbe
vvloua •tte vt.alU 011 wludl we have the GP1)0rtuDJty to collaborate.

•••umed

We ext•id to you an opea 1DY1tatlon to vult ow t.natituUon, and if
yau will aciY1N u 1D adftnc:18. we will arrange an aqenda fa your
S'Wiaw of the ftdDaa aat1Y1t1ea ._. lD wbJcb you mlqbt be lntereated.
Abo, when you come to HOUfloG, we would Wee f0I' you to qtve a
pn■-datJoD to oar ataff. If you can, w e would be happy to reJ.mbune
yau far your

apen••.

81Doenly

yowa,

R. Lee Clark, M . D.
Pre■ 1dent

RLC:jb
be: Dr. G. B. BlumeMchein
Dr. R. C . Hickey

~
ILL·1no1s cAnceR counc1L

-..,\-

l .1

J7 /outf\ UJobo,t\ AYenue•CNcogo. llnol,6060J•Jl2-J46·981J

January 11, 1977

R. Lee Clark, M.D .
President
The Un iversity of Texas System
Cancer Center
M.D. Anderson Hospital and
Tumor I nstitute
6723 Bertner Avenue
Houston, Texas 77030
Dear Lee:
This is just a brief note t o tell you how much I enjoyed the
mee ting of the AACI in Houston . Unfo rtunat ely I had to rush
back because of sor.1e press ing business in Chicago and consequently I missed the opportun ity to visit with you as you
su~gested. I will, however, t ake a raincheck on this invit at1on, since there are many things which I would like t o
l earn from you.

Again, ~any thanks for your hospitality.
Sincerely yours ,

Jan W. Steiner, M.0 .
Director Designate

JWS:sa

JD i,,,

Mr. E. R. Gilley

January 25, 1977

Office of the Presid ent
1977 AM~l Dues - AHoclaUon of American Cancer In■Utute■
Thu memo J■ a r9queat foe you to remit the 1977 aMual dues, ln the
amount of $500.00, to the A■■ociaUon of .\Jnwlcan Cancer I nstitutes
for our 1n■UtuUon.
As reque■ted on the enclosed ■tatement. please make the check payable
to the A■■oclaUon of Amwlcan Cancer lnaUtutes and send 1t to the
following add.tea ■:
Dr. E. A. MJrand
S ec:retary-Trea■ww

Associallon of American Cancer Inat1tute1
Roswell Park Memorial InaUtute
666 Elm Street
Buffalo, New Ycxk 14203

Yau may wish to uae the same source of fund• as used ln previous
)'HrS.

R. Lee Clark, M . D.
President

RLC:Jb
Enclo1ure

·-

association of american cancer institutes
OFF:cus
PRESIDENT ALBERT H. OWENS. JR., M.O.
John Hop/tins Unlwrslty Onco/09y c,nur, Bofr1mort. Moryland

..

VICE PRESIDENT WILLIAM W. SHI NG LETON . \ I.D.
DtA• Compn~M/.,. u,nc,r Cmt,r, Durham, ;'Vorth Coroltna
SECRETAR Y-TREASURER E.A. MIRA'1,0. Ph.D.
lfos..,.11 Pr,rlt M~moritl/ /nstl ruu, Buffalo, No,• Yor#

.January 19, 1977

MPJI)

TO:

Dr. R. Lee Cla r k , Univer sity of Texas System Cancer Center

PROK:

Dr. E. A. Mirand, Secretary-Treasurer

SUBJECT:

Annual Dues for 1977

Annual dues are established by the Board of Directors
of the Association of American Cancer Institutes in such amounts
u it deems necessary to defray operating expenses. It has been
reccn.ended by the Boa.r d of Directors that these dues should be
$500.00 for each regular member organization in the AACI. Please
find enclosed a statement for the annual dues for the year 1977.

Please make your check payable to the Association of
Aiaerican Cancer Institutes, attention of Dr. E. A. Mirand,
Secretary-Treasurer. It would be appreciated if payment of
the annual dues could be made by February 15 , 1977.

. ~O\~
....'·" :-.'
....
\\

E.AM:co
Enclosure

(\ ,\

\

~

-~ ~.. ::•.,;t

90ARD Of DIRECTORS

R. Lie Cwt, M.O., Otalrmm
Ht#IJtrln, ,.,..,

,,..,.,.,,, r.,.tn

G. Offlnun tbmmond, ~1.0 .
Lor An,.ln G,iilom,o

Elward I. luttie, Jr., M.O.
,._, Yor•, 1-w Y,,,_

Lewis L Coriell, M.O.
a.,._,,,._,tt#Y

lletllton, W/Jconsitt

Mumy M. Coi,elllld, M.O.

Olrtlt A. EwMII, M.D.

s-dr,......,.,,,

H,ftfY C. Pitot, M.O.

ASSOCIATION OF AMERICAN CANCER INSTITUTES
Annual Dues for 1977

Regular Membership - - - - - - - - - - · - - - - - - - - - $ SOO.OO

Please make check payable to:
Association of American Cancer Institu t es

Send to:
Dr. E. A.. Mirand, Secretary-Treasurer, MCI
Boswell Park Memorial Institute
666 Elm Street
Buffalo, New York 14263

!Q'.!!_:

It would be appreciated if dues could be paid by Feb. 15, 1977.

January 18, 1977

Dr. Albert Owen•
Director
Johna Hopkin• Univen.ity Oncolcoy

Center
332 Carnegie
BalUIDOl'e, Maryland 21205
Dear Al;
Thank you for your thouvhtful comments regarding the AACI meet1n9.
I believe 1t was a moat successful meeUng with a good repreaentaUon
of the members.
Your lnvitaUon to participate tn the dedication ceremonies of the Johns
Boplctna Center 11 certainly appreciated. I have a scheduled American
Cancer Society EJCecutiYe Committee meetlncJ April 13-15 and as I
menUoned a proposed trip to China b991nning Apcll 18. This trip ba1
not been confirmed aa of thia date however I am hesitant to make
other commitments at th1I Ume.
We have ordered a repreaentaUve group of picture• from the dedication
activiUea and tbeae ahould be available in the near future.
Sincerely yours,

R. Lee Clark, M. D.
Preaident

Rl.C:Jh

P. S . The Dedi cation of your facility has the highest priority - however,
China says I must attend - any o ther time for you and I will make i t .

·- ·

1

THE JOHNS HOPKJJlS UNIVERSITY

I

SCHOOL OF MEDICINE
ONCOLOGY CENTER
J01•9JS-1JOO

•

THE JOHNS HOPIUNS HOSPITAL

BALTIMORE. MARYLAND 21205

January 13, 1977

Dr. R. Lee Clark
University of Texas System Cancer
Center
M.D. Anderson Hospital and Tumor
Institute
Texas Medical Center
Houston, Texas 77025
Dear Lee:
I am sorry that I didn't get a chance to say good-by before I had
to leave for the airport. It was a good meeting and, as usual, you were
a most gr~c iJus host. Please know how much all of us appreciate the very
fine arrangements which you and your staff made.
You will recall that we spoke about your particfyating in the dedication
of our Center at Hopkins on !E,ril 17-18 . A~ .l un.der.stall9.....!!.a._Yoy were <;.QJl~er n ed -t ~ i~ -~
: be leav.!B&. fo_!" ...9tina then. Bo~ver please let m~
know whether your memory was correct gr not . There are many reasons why I
would ~
-ro·-nve you participate in the dedication, so I hope you will find
that your cal endar is clear.
I will mention one other item that I am still concerned about. You will
recall that I participated in your dedication ceremony a few months ago. At
one point you indicated that some one in your office might be kind enough t o
send me a few photos of the occasion when they we re ready. I don't believe
anything ever got to me and I would still appreciate receiving a remembrance
. of the event if it's not too much trouble.
Sincerely,

Albert B. Owens, Jr., M.D.
Direc tor
AHO:rar

Januery l 7, l 977

Dr.

Tape■ It.

Pradhan

A a■latant

Prof. .■« of Oncol09y
Howard Uni'ftnlty Cancer Reaearcb Center
2041 Geocvla Avenue, N. W .
¥. a ■hiD9ton, D . C . 20060
D ear Doctor Pradhan;

vow Jett« of January 13, and your tnt.ere■t in the
of American Cancer In■titutea. I am forwanllng your
letter to Or. t. A • Mirand • Secnta,y-Trea •urer of the Aa■oclation,
■o that be may
you tbe iofOl'maUon you have requested.

¥l e appqctate
u■ociatton

••ad

Thank you foe your lntereat.
S incerely yo&ra,

I

R. I.ff Clark, M . D.

President
RLC:Jb
cc: Dr. t. A. Mlnand

j,61r _

!.__
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BOWARD UN1VERSITY CAN CER RESEARCH CENTER
COLLEGE OF MEDICI NE
WASH l!',,QTON, D . C. ' 20059
OFflCl 01 l)ll ASSOCIAlf 0 1~K1oa
..,.. Code 202-462,14M

J anuary 13, 1977

0£P>JIIMENT OF ONCOI.OGY
liOW>JIO UNIVERSITY liOSPfTA\
2041 6-o,vl1 Aven.,., N ,W.
w, ...i,,g,.,,,, D. C. 200dO
,~s.1406, (11, oe. 09

Dr . R. Lee Clar k
President
University of Texas System Cancer Center
:-1. D. Anderson Hospital and Tumor I nstitute
Texas Medical Center
Houston , Texas 77030
Dear Dr. Clark:
l would like to receive the follov.ing information regarding member ship in the Associati on of American Cancer Institutes (AACI) :
1.

Elibility of membership .

2.

Annual me.m bership fee .

3.

Annual meet ings organized by ACCI .

..

Other relevant information r egarding t he MCI .

I

If possible, please s..cnd me an application form and other informative
material o f the AACI, at your earliest convenience.
Thank you for your kind attention.
Sincerely ,

Tapas K. Pradhan , Ph . D.
Assistant Professor of Oncology

TKP : bjo'::

association

;O,'JJ

.

of amencan cancer institutes
OfFICLRS
PRESIOLNT ALBl P T H. 01\ f M . IR., M.D.
John Hupklns

)

u,,,.,.,, •• Onwlo:,) c.-..,,,.,. 81,

...,,,.,, II.Ir) ., ,

VICE PRESIOCl'I. r 11 ILLl;\M W. 'iH INC. LrTO'I, "1.0.
Dukt Comprthtn<frt Ct111ctr Crr.ru, f>urh,m. \ o•~h ~-al ,..,

SECRETARY TRCAS URER E. A. MIR,\!11D. Ph.D.
Ros-II Purl. 4ft.mo•i<:I l n,tltuu, Bulla!<>, '\'," ~,

January 10, 1977
Dr . Dem:ia n Hammond

Los Angeles County
University of Southern
Califor nia Comprehensive
Cancer Center
2025 Zonal Avenue
Los Angeles , California 90033
Dear Denny:

The concerns expressed in your l etter of January 3 to Ed Mirand
distress me . The wording of the minutes is unfortunate and the implications you drew , though understandable are not correct.

My purpose in responding is to assure you that the AACI ~oard of
Directors is very grateful for the liaison service ~-hich you performed
~-ith the ACCC. No expressions of dissatisfaction entered our deliberations. On the contrary , we were concerned that the good work you
started be carried on by a suitably qualified s uccessor who could devote
t he r equir ed t.iJ:le and ener gy to the work.
I believe that a great many of us are working far too har d at too
many tasks. As the AACI gro.s in membership, mor e individuals should
share in t he responsibili t y of carrying its work forward . It ~~ s ~i th
these genera l pe r ceptions in ~ind that we acknowledged your r esignati on
and asked ,Lohn_ Yar bro to serve as your successor in the ACCC l iaison
~·ork.
I hope this " sets the r ecord straight". I know everyone on the
Board would wish to join c e i n thi s e.xpressi on .

Sincer ely ,

Albe rt H. Owens , J r. , M.D.
Pr esident
,\H() :rar

cc :

!fist1tI E~tbitsCiark

BO~RDO

and E.A. !'tira nd

\ :urr,,

ll. l tr (.!1 • 1.. . '1.D.. o,,.,.m.ir
Hr,-~,t"". Te,u,

HOI.Tit""

E.s•• •~ J. 801:1,, fr., \1. 0 .
·. ,,,,,,. )'c,,t ·\ ' " ,~o.rlc

0z,,a_.,,_ ,.-.. Jr•,:,

\1. (.,r,dJnJ, \I.O.

rt\o,

Lr ..;~ L. C.u11rll . M.O .

ChAok's A E,ani., M.0 .
5Nt!I<', Wos.,/r,,1ton

C. O,nmJn

M,•"1\-.,,,•J. \1 O

L OJ A r _yt,.,

C..

, .., _,

t-lrnr, C. P ,101 . \1.0 .

..,,.,J ,on.

1: '\..<Pf: , ,~

~

...
LOS ANGELES COUNTY- UNIVERSITY OF SOUTHERN.CALIFORNIA
COMPREHENSIVE CANCER CENTER
2025 Zonal Avenue• Los Angeles, California 90033 • (213) 226-2008
OFFICE OF THE DIRECTOR
KUTH509

January 3, 1977

Or. Edwin A. Mirand
Roswell Park Memorial Institute
666 Elm Street
Buffalo, New York 14203
Dear Ed:
I would like to provide clarification and correction of the minutes of the meeting of
the Board of Directors of the Association of American Cancer Institutes which was
held in Houston on Oct ober 1, 1976. On page seven there is reference to my
resignation as the re?resentative of the AACI to the Board of Directors of the
Association of Commt.:.nity Cancer Centers.
The minutes imply t:,.a1 the ACCC expressed some dissatisfaction with my lack of
interest and that my :-esignation had been requested by the ACCC since they had
been "miffed" by my ~!ormance.
The minutes are inccr.-ect in these respects. I feel that the liaison between the
AACI and the ACCC :.s an important one, so I gladly accepted designation as the
AACI representative .o the Board of Directors of the ACCC. I attended two
meetings of :he ooar::l oi Directors and have reported on the activities of the
ACCC at the meetings of the AACI on at least two occasions.
I have been an active supporter of ACCC since its inception. I originaHy proposed
to AACI that a Haison :>e established. I have provided to ACCC on two occasions
detailed letters in Sl..'Pport of applications submitted by ACCC to the NCI.
After a year, I felt I could not continue to give membership on the ACCC Board the
priority which it deserved, so I advised Or. James Donovan that I wished to resign,
and would request Dr. Owens to appoint another representative. I advised Dr.
Owens of this verbally last spring. Since I was not aware that any action had been
taken, I put my resignation in writing to Dr. Gayle Ketterhagen, president of the
ACCC and to Dr. Owens, in the summer of 1976. I received a very kind letter from
Dr. Ketterhagen understanding the reasons for my resignation and generously
appreciating the contributions and suggestions I had made to ACCC.

Dr. Edwin A. Mirand
January 3, l 977

Page 2.

I would like the record of this meeting to be corrected since it implies that I Jack
interest in the ACCC and that the ACCC somehow initiated my resignation from
its Board of Directors. I don't believe either uf those implications is correct.

Thank you very much.

Sincerely,

~~.~,~Director,
Associate Dean

DH/acp
cc:

Alben Owe.'15. \1. D.
President, :\.~O
Johns Hopk:ns Cr.iversity
R. Lee Cl.ar~A ~LD.

President
M~D- Anderson :iospitaJ and Tumor Institute

TH'lftNIVERSITY OF TEXAS S.EM

CANCER CENTER
Hoi,., lon, 7'~xu
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Edwin A. Mir and: Ph . D.
Associ ate Inst i tute Director
Roswell Par k Memor ial Institute
666 Elm St r ee t
Burfa lo, New Yor k 1t263
De a r Dr. Mi r and :
Enclosed is the dr aft o~ the AACI Boar d of Dir ector s minutes
for your app r oval ~nd dist r ibution . ~either Dr. Clar !{ Por
you attended tt-e rr.eeting (l)r . Clar r.: was pr esen+ for appr cxi mately ::..o :ninutes' . so we also :for w'.irded a COFY of the dr aft
to Dr . Cwens, who ~esided at this meeting and is tr.e best
;-er son to chec-': tt,e accur acy o!' '-he infor mation included .
Pe r haps :;ou wc:.tld lil<e to chec!C wi-'-ri Dr . Q\,rei.s regar di:-:g his
opinior. of the mi~utes befor e they a r e fin•lized and dist r ibuted .
~egr e: ~ha~ you ~ere ~er e sc ~riefly . as 1· is always sc
'>li ::-. you sr.d '"o i:ear :.1cur views and pe r s-ipecti ·:es of t~e A.4CI acti\•i•ies "lr.d o .. her :r.a~ters . I hope
you wil: ~e her e for a longe r rericd of :ime in Januar y, and
I s i nce r ely ho;e the weather will be better her e tnan in
Buffalc . I can almost guarantee ~~at it will not snow her e .
~

r leasant to \•isi t

f1/ s . ) 3 . J . Kolenda
Researcn Analyst

Encl.
cc : Dr. A. H. Cwens, Jr .

c,..
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PRFSENf:

Dr.
Dr.
Dr.
Dr.
Dr.
Dr.

Albert Owens, President (presided)

ABSmr:

Dr.
Dr.
Dr.
Dr.

Cllarles Evans
Deman l:lamrond
E. A. Mirand
Henry Pitot

GJESTS:

Dr.
Dr.
Dr.
Dr.
Dr.
Dr.

Janes ~
p. Denoix
E. J Freireich
Albert E. Gunn
Felix Baas

R. lA3e Clark, Cbainmn
E.J. Beattie
M. M. Copeland

Lew.is Coriell
William Shingleton

Robert Hickey

Dr. Clark

v.'35

Department of Virology, lllAH
ln.stitut Gustave Roussy, Villejuif, France
Dept. of Developnental Therapeutics, lllAH
Head, Rehabilitation Center, KWl
Office of Research , MDAH
Director, IIWi

delayed in arriving at the meeting, and Dr. Owens

presided.
l~ restrictions

n l!l>s

Dr. °'1eDs invited Dr. E. J Freireich to give a brief review of the

presentatioo he prepared for the President's Cancer Panel meeting during
the afternoon.

1be essence of the presentation was tbat the regulatory

mechanisn of tbe FDA with regard to Investigational New Drugs (INDs) for

cancer patients bas becare so repressive that clinical research in cancer

centers bas essentially been halted .

The chief problem is the detennination

of the FDA to interpret the protective laws intended for healthy citizens

in exactly the same nrumer for cancer patients, who are facing potentially
fatal diseases for 9,bich ~1-essive therapeutic measures and new drugs are

essential.

-

-

The obstructive nature of the IDA regulatory interpretations

.

-
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is based, not on clinically infonned judgments of the efficacy or toxicity

of drugs, wt oo nonnedical natters such as progress reports, foms to
be coopleted by specified deadlines, nllli>ers of animals on which drugs

were tested, etc. and regarding infonned consent \\Ording, \\bich the IDA
interprets as "coercive" wben tenns such as 'therapy", ''treatment",

etc. are used.

PA p ~ l s in

In addition, FDA proposals published in tbe Federal. Register (August 20, 1976)

re~ister
: "experimental

include 11 rules for disqualification of investigators (Append.ix I) 'Mli.ch

~ices & in vitro
ri
,des"

are so restrictive and punitive that clinical and nucb basic research will
be brought to a virtual standstill.

ecmi:>inant mA
~

Or. Felix

Haas (Head,

Office of Research, WAH) pointed out that the

regulatioos dealing with recaii:>inant mA studies are so loosely written
and my be so restrictively interpreted and regulated that cancer research
in alm:>st every field that includes in vivo and in vitro DNA research might
be affected.
l ~ t e d Fonnal

biectlons

Dr. Albert Gunn of WAH, who has both an M.D. and L.L.D. degree, was invited

to make sane ranarks regarding tbese issues.

Dr. Gunn had discussed these

natters recently with a senior FDA a1ployee.

He ascertained that (1) FDA

does indeed intend to scrutinize the NCI !IDre closely in the future;
(2) n>A does not agree that the desperate status of cancer patients justifies

any different interpretive position than the IDA is taking for healthy
citi.zen.5, (3) the new IND regulations are not substantially different than
the previous ones, (4) FDA has always had the pa.Yer to disqualify inves-

tigators wbo were guilty of infractions of regulations, and that the only
differences were in the reasons for disqualification.

An

exanple of this

is that presently, if the investigator has obtained a proper

infonned

--

-

oonsent fran the patient(s) and begins the research project but has not
sought clearance fran bis/her institutional surveillance coorni.ttee, the
investigator is disqualified pernanently and his/her nazre is published
widely within the scientific camunity.
Dr. Gunn ~ e d that rmny i .o dividuals within the scientific and clinical
should
coommity,J;object strongly to this and similar positions taken by tbe FDA
and claim that there soould be strong evidence of willful intent to disregard

regulations before such strong action is taken by the. FDA or any other
regulatory organization.

The very nature of research requires freedcm of

judgnpnt; and action, and unless there is evidence of fraudulant intent,
such restrictive interpretations of the law sbould

~ested

jections to:

1.

be prohibited.

Penmnent disqualification of an investigator for infractions without
evidence of willful intent; wide publication of disqualification.

2.

Detenninati on of validity of experiment by non-qualified regulatory

personnel; penmnent denial of further INDs or investigatiooal devices
if experiment judged not valid.
3.

Institutional suspension if any meot>er of the institutional research

team is under tarporary suspension.
4.

Release of patient names to FDA and other regulatory agencies upon
demnd; violates tbe traditional patient-physician coniidentiality;

cannot and should not be done unless patient consents to the release
of the infonm.tion.
lead1 ine for

k.;smnses to
W'!II.'

R8nJlations

A certain urgency is required for CCJJl)liance with the opportunity to respond

to the new regulations prior to finalization.

A letter, dated Septelber 30,

indicated that <ktober 19 \lOU.l.d be tbe deadline for receipt and oonsideration of responses, although there is sane indication that the cx:mnittee will
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begin to finalize tbe regulations October 4.

-

It is believed, however,

that the ccmn:ittee will consider objections that arrive past tbe October 19
deadline.

Mr. Merrill is tbe General Cowisel and Miss Hunter, in P.tr.

Merrill's office, is the individual within FDA MX> is responsible for
receiving the responses.
1.

Otber suggestions were:

Strong objections to the attitude of FDA that an investigator (and his

institution) is guilty tmtil he is proven to be innocent.
2.

Before these regulatioos are Iinali.zed and adopted, others should be
drafted spelling out disciplinary action to be taken against FDA

regulators who are guilty of rm.king ''frivolous decisions which are

detrimental
3.

to tbe

conduct of a valid research project".

Dr. Gunn suggested that, when the opportunity presents itself, accused

investigators or institutions attend discu.ssioos of infractions
ar.cropaniP.d by legal ool.lllSel with the right of cross examination.

IMcl Position

It was agreed by the Board of Directors of the AltCI tbat the organization
DJ.LSt go

on record in opposition to the restrictive attitude and regulations

of the IDA with regard to clinical cancer investigative ~rk.

tl£fICJj
Dr.
~ted bv the Board

~

intends to write to Gordon Zubrod and Bnil Frei requesting a

statsnent regarding the position to be taken by clinical investigators which

can be endorsed and sutm:i.tted as a resolution by A/ICI to the President of
the U.S.

tlGtIW

Dr. C>.vens intends t.o draf-c a cover letter to accoopany the l etter drafted
by Drs. R. Lee Clark and Robert C. Hickey to Mr. Sctmi.dt of the Federal Drug

Acministration indicating tbat the Board of Directors of the AACI oonsiders
the medical needs of cancer patients to be draJJBtically different fran those

of the average healthy citizen and believes that special considerations
need to be IIB.de with regard to regulatory procedure in 'IDni toring the use

l

_,.
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of investigational new cancer drugs (Appendix II).

If time pennits, this

letter will be circulated aroong the MCI OlEJli>ers for e nclorsenent.
Goverarental

lepresentatives

Dr . Copeland suggested , and the Iba.rd endorsed, the need to oontact
personally all goverrmental representatives and enlist their support in

tmirtaining the freedan so necessary to oonduct effective research, and

.articu .irly cancer research.

b. tiooal 1\m)r
rettistrars I Assn •

Dr. Copeland referred to a letter (Appendix Ill) addressed to Dr. Owens

regarding the National 1\m)r Registrars' Associatioo (NIRA) which was
recently organized (May 14, 1974).

of approxinlltely 700 bosptials

niese registrars represent 295 bospi tals

v.nose

cancer services and ttm:1r registries

are approved by tbe American College of SUrgeons.

1be purposes of the

organization are to pramte education regarding the value of tlJOOr registries

.

and to encourage a higher quality performance in the maintenance of tll'IX)r

registries, to be of benefit to cancer patients and to physicians.

Io the

future, ment>ers of this orgwliz.ation intend to assist other hospitals to
organize registries and to encourage DODl1Bli>er registries to join the
orga.niza tion.
lrllrpby

Dr. Mayer of the American College of Surgeons, Dr. Gerald

of Roswell Park Marorial I nstitute, and Dr. Copeland are advisors

to this group.

Dr. Copeland ti::<Xlmended to the group that, rather than

atteq>t to establish an independe nt national headquarters, they affiliate

with a senior nedical organization such as the MCI, a suggestion to \\hlch
they were very receptive .

Dr . Q)peland believes that if this organization

\\Ould beadquarter in one of the menber AACI institutions everyone \liOUld

benefit nore than if it

t ried to function independently.

Mrs. Vida Peterson

of Pittsburg is the President of the NIBA, and she and other officers seen
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ve ry enthusiastic about assistance fran an organization such as AACI in
obtaining contracts and grants in the future.
The Board

Na'JW

namers

agreed that discussion

of affiliation with the mllA should

be included oo t he agenda of t he J anuary 1977 neeting of the MCI.

Dr. CMens

asked Dr. Copeland to obtain nore infomnt ion about the organizat i on and
sutmit it to him and Dr. Mirand for wide circula tion anong AACI

nemers

before the January meeting, which Dr. c.opeland agreed to do.
h

bas cane to the attention of several AACI menbers that at a meeting

in Chicago of carprebensive cancer center representatives of the cancer

control outreach prograns, discussion occurred regarding the possibility
of creating an independent organization for cancer cootrol activities.
was agreed that what

A£PCJi

wa.ud

It

be attenpted by such an organization would probably

overlap and possibly conflict with t he AACI Task 12.

Dr. Beatt i e agreed

that he would discuss the exact objectives o f t he organiz.at i on with Dr. Guy
Bobbins,

woo

c haired the Chicago meeting, and report back t o the Ek:>ard ne:ii:lers.

The AACI contract to carry out the 12 tasks is s till a.waiting negotiation ,
and Dr. o.vens bas an appointment with Dr. Guy Newell on Tuesday, October 5
to discuss the status of the contract.
Cn August 10 several neJi>ers

of the MCI

\\l8re

a t t ending a meeting i n Washington,

and a ve ry well-infonned attorney , Ms. Lillie Engstran,

wbo

is affilia t.ed

with aP Associates, gave an excellent sumary statement of t he Heal th

Services Agenc ies and a suggested p.lan of action.

I\GI19ti

It was suggested !llld

approved by the Board that Ms. Engstran be i nvited to give the s ame
presentation to the AACI meoi>ers at the January neeting.
The Association of Crnmmity Cancer Centers bad its grant application
disapproved by the rcl, and no IDE!IDer of the Board knows the exact s tatus
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of the organization at this tine.

Dr. Demnn llarnoond was appointed by MCI

to be liaison nerber to the NXr, meetings, but be bas not attended any

meetings since be was appointed.

The te:r, is slightly miffed about the

apparent lack o{ interest, and Dr. Hmrmod bas resigned fran the appointment.
'Ihe

lbard approved the awc,intment of Dr. Jam Yarbro as the A/C,I liaison

rrsrber to the MXr., since be is already on the K:JX Board of Di.rectors.

The NJ:r, is preparing suggestioos for changes in the National Cancer Act
and the AACI needs to be infomed about what their pl'Oj)OE,i8..1s are.

btiooal

froposed

ea.

Act
Olanges

'Ibere was brief discussion about the 9 proposed changes of the National Cancer

Act.

It

V.1LS

agreed that the APCI 'M>llld

eooorse

the suggested change that

\liOUld give the Director of ?CI authority "to collect data v.hlch exists in
\>arioos tuIDr registries and cancer research data banks throughout the
COWlt.ry"

only if the infonmtion sought is ttllDr registry infonmtion and

not cancer patient data

such

as that which

the AACI aeli>ers inte nd to exchange

with each other wider Tasks 3,4,5 of the MCI Plan.
It was suggested that Dr. Clark be asked to give a presentation to the Board
regarding the National Cancer Act changes, about wban to oootact and

specifically about what.

(Dr. Clark was unable to attend tbe Board meeting

for onre than a few minutes because of a conflicting meeting f o r which be was
e.'(l)eCt.ed to be host. )
~I IntrainstituDr. Clark (past MCI president) , Dr. ~DS ( current president) and
t.ional c.amu ttee
to Consider Centers Dr. Shingleton ( president-elect) were previously appointed as a liaison
c.anru. ~ r-er- o f tbe MCI to meet at regular intervals with the Direct o r of

tel and NCI s taff meni>ers to discuss tbe role of cancer centers of tbe
COW\try in tbe National cancer Plan.

All agreed to meet at least 4 times

per year to discuss (1) cancer center funding, (2) responsibilities and

. ·..
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resources of the tel as related to the caq>rebensive cancer centers and
(3) the defined priorities in the centers' role in the national progr.un.

n1e Board rrewers agreed that, since Dr. Rauscher is to leave his position

as Director of NCI on NovE!Ii:>er 1, 1976 and since the NCI budget bas oow been

IQ'UI/

approved by tbe Congress over the President's veto, it is urgent for center
directors to discuss the budget allocations of the ? C l ~ ~ with
Dr. Rauscher.

Dr. Owens

expressed his intention to discu&; such a meeting

with Dr. Rauscher v.bi.le be is attending the dedication of the Anderson
wildi.ngs in ~too, and would suggest that Mr. Cal Baldwin, a.tdget Cffice~

attend the meeting with Dr. Rauscher.

The Boa.rd rrerbers agreed that there is

a great need to upgrade the image of tbe cancer centers, and that probably
the best mecbanisn will be the patient data system which will datnnstrate
that the centers are doing a better job of increasing su.rvi\-a.l of cancer

patients~ extending useful life even wnen cw-e is not achieved.
·c1ates for
~tor-NCI

lblrd

nl:l'li)ers

reviewed tbe names of the 12 suggested candidates for the

position of Director of tel to replace Dr. Rauscher.

It was agreed that the

AACI should take no official position regarding the candidates but should
endorse candidates individually.
nterest in
Dr. Hickey info:nmd the A/tel Board nemers that t he UICX::: Carmi. ttee for
Patient Data
International Collaborative Activities (CICA) is very interested in
participating in the AACI Task 3,4 ,5.

Dr. Hickey indica'ted that all problems

regarding nc:r:mnclature and staging have been solved and the systan is ready

w

be inplaneoted, but that the OCI is still ''foot-dragging" about the

contract to be awarded for the systen.

Dr . Rauscher announced receotl}'

that he wishes for each OCI division bead to cut bis/ her budget by 3%, and
Dr. O'Conor agreed to cut the OCPOO fran his budget and to put the project

. . . . ...
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•
out for c.oopetitive contract negotiation.

The Board neroers agreed that

probably the best thing to do is to forget about the proposed AACI contract
for this task activity and to initiate the system :imnediately wrong tbanselves.
Dr. Hickey said the grant proposal is alJoost COJl)leted by the Anderson l:fospi tal
to COJl)ete for this system and t hey plan to go ahead with it.

Anderson has

been ready since January 1976, and if any of the other AACI institutions

wish to be involved in the systen and provide their data, the system can

erTJP§

begin 11T1JECliately.

Or. Beattie and Dr. Shingleton said their institutions

are r eady to begin, and tbe other Iblrd meoba"s expressed their willingness
The. consens1..s_ was _
to participate.jtllat it probably is oot necessary to try to get 11 or 12 of
the MCI mmi>ers together before begin.'ling, and that since tbe CICA is

interested , we should go ahead with the original plan to do this independently

of NCI.

The CICA trerbers seem to wish the AN.;I to lead in this enterprise.

It was suggested that, if the tel grant or contract funding

ooes

not

nnte rialize , a charge per patient entry in tbe systan could be made to
each institution for use in support of the system.

WAH can serve as the

headquarters in the USA and lnstitut Jules Bordet in Brussels for lillrope.
WAH will go ahead with the grant application siLce so D1lCh work has already

iafI1£ii

been dooe on it.

This plan will be subnitted to the full meni:>ership at

the January rreeting of the AACI.
~

e nesis

Dr. Shingleton gave a progress reJX)rt on the arranga:nents for the

Cu-cinogenesis Worksoop to take place imned:iately following the AACI meeting
in January in Houston.

There was sane confusion about whe n the Carcinogenesis

meeting is to begin - Dr. Shingleton said the afternoon :>f the 11th, but
the agenda has the AACI meeting scheduled fo- cwo full days, the 10th and the

11th and the carcinogenesis meeting for the 12th and 13th.

All concerned

. . ....

..
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were to check out the original correspondence to clarify this natter.

It was suggested that another Board oI Directors soould take place at that
tine, but oo final tine was chosen Ior the maeting.
The neeting was adjourned at 12: 10 p.m. for :l -..ncb.

Minutes pr epar ed by Ms . B. J . Kolenda
Res earch Analyst
M. D. Ander soP Hospital
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January 5, 1977

R. Lee Clark, H.D.
President
M.D. Anderson Hospital
6723 Bertner Avenue
Houston, Texas 77025
Dear Dr. Clark:

Thank you for your thoughtful telegram and the kind sentiments therein .
We will very much look forward to working in the capacit y of a Co111prehensive Cancer Center with you, the A.A.C.I., and with our count e rpart
Comprehensive Centers in the National Program tovard our commonly-held
objectives.
Very best wishes for th,• New Year!
Sincerely,

?ffJ,.,,C/,/
Richard J. Steckel, M.D .
Director, UCLA Comprehe nsive Cancer Center
RJS:rn

I\
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DR. RlCH"~D
DDtEC'l'Olt

J.

:tTECOL

UCLA CANCER ~YER
UCLA MED1CAL ctJiftlt
~:?, v ·E.:rv.cco e1.vo.
LOS ANGEJ,ES., CALIPOIOllA 90024

CONGRATUUTIONS UPON YOUR RECOGJflTIOH AS A COMPRERERSlVE CANC&Jt CDn'Elt. ALL OP US WBO HAYE SEEN YOUI
EFFOltTS FEEL lOU ARD TOU1I S"l»T HAVE 001ft A SU?ERB JOB
(CCN11NU&D ON PA...~t 2
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